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Zusammenfassung 
 
Die Calsyntenine wurden im Labor von Prof. Peter Sonderegger im Rahmen 
einer Suche nach axonal sezernierten Proteinen mittels eines kompartimentierten 
Zellkultursystems und zwei-dimensionaler Gelelectrophorese entdeckt. Die drei 
Mitglieder der Calsyntenin-Genfamilie, Calsyntenin-1, -2, und -3, haben eine 
Aminosäuren-Identität von ungefähr 70%. Die biologische Funktion der 
Calsyntenine ist noch weitgehend unerforscht. Eines der bisher festgestellten 
Charakteristika der Calsyntenine weist darauf hin, dass eine Region mit bevorzugt 
sauren Aminosäuren im zytoplasmatischen Segment von Calsyntenin-1 bei der 
Verarbeitung von neuronalen Calcium-Signalen eine Rolle spielen könnte. Auf 
Grund der Calcium-bindenden Funktion des ersten Vertreters wurden die Mitglieder 
dieser Genfamilie als Calsyntenine benannt. Die Calcium-bindende Funktion des 
zytoplasmatischen Segments von Calsyntenin-1 motivierte uns zu den 
vorliegenden Studien, welche zum Ziel hatten, eine mögliche Rolle der 
Calsyntenine im Excitotoxizitäts-induzierten neuronalen Zelltod zu studieren und 
charakterisieren. 
 
Anstelle der zeitaufwändigen Erzeugung des Gen-Knock-Outs bei Mäusen 
verwendeten wir Vektor-basierte siRNA (small interfering RNA) um die Expression 
und Funktion der Calsyntenine zu unterdrücken. Die siRNA-Sequenz, welche einer 
Sequenz des angezielten Gens entspricht, wurde hinter dem Promotor der 
RNA-Polymerase III eingefügt. Die resultierenden siRNA-Transkripte imitieren 
Zwischenstufen des RNA-Interferenz-Weges, welche schlussendlich den 
Sequenz-spezifischen mRNA-Abbau zur Folge haben. Mittels EGFP (enhanced 
Green Fluorescent Protein) als Ziel-Gen konnten wir mit unserem Vektor-basierten 
siRNA-System in den Säugetier-Zelllinien HEK293T und NG108-15 effiziente und 
spezifische Gen-Suppression erzielen. Ebenso wurde die Expression von 
transfiziertem Calsyntenin-1 durch die Co-Transfektion eines 
Calsyntenin-1-spezifischen siRNA-Konstrukts, pBlueU6-siCst1.1, in der 
Neuroblastoma-Glioma-Zelllinie NG-108-15 stark unterdrückt.  
 
Die effiziente Einführung eines fremden Gens in eine Nervenzelle ist mit den 
heute gängigen Transfektionsmethoden in der Regel schwierig. Deshalb haben wir 
einen Vektor zu Hilfe genommen, der aus dem Adeno-assoziierten Virus (AAV) 
entwickelt wurde. Unser rekombinanter AAV (rAAV) mit der siRNA-Kassette gegen 
Calsyntenin-1 wurde in 90% der Neurone aufgenommen. Die Analyse der Zellen 
mittels Immunoblot und Immunozytochemie zeigte eine Suppression von 
Calsyntenin-1 von bis zu 60%. Auf die gleiche Art konnten wir auch die 
Ueberexpression von Calsyntenin-1 herbeiführen. Wir zählten die primären und 
sekundären Dendriten der Neurone mit Knock-down und Ueberexpression von 
Calsyntenin-1 und inspizierten sie bezüglich morphologischer Auffälligkeiten. Zum 
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Schluss untersuchten wir die Reaktion von Neuronen, die mit rAAV infiziert wurden, 
nach Exposition von 100 μM NMDA, um einen möglichen Einfluss von 
Ueberexpression oder Mangel an Calsyntenin-1 auf den Excitotoxizitäts-induzierten 
neuronalen Zelltod zu ermitteln.  
 
Die bisher vorliegenden Resultate nach rAAV-induziertem Knock-down und 
Ueberexpression von Calsyntenin-1 lassen noch kein abschliessendes Urteil 
darüber zu, ob Calsyntenin-1 eine Rolle beim Excitotoxizitäts-induzierten 
Nervenzelltod innehat. Insbesondere werden auch weitere Experimente notwendig 
sein, um die Rolle der anderen Familienmitglieder, Calsyntenin-2 und -3 zu 
studieren und deren mögliche kompensatorische Rolle nach der Ausschaltung von 
Calsyntenin-1 zu ermitteln. Zur gezielten Ausschaltung aller drei Calsyntenine 
wurde bereits eine siRNA-Kassette konstruiert, welche eine Sequenz enthält, die 
eine den drei Calsynteninen gemeinsame Sequenz anzielt. Damit sind die 
Voraussetzungen für einen Triple-Knockdown der Calsyntenine gegeben.  
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I. Abstract 
 
Using a compartmentalized culturing system and two-dimensional gel analysis, a 
novel protein family was discovered in embryonic chicken neuron cultures in the 
laboratory of Dr. Peter Sonderegger in 2001. The three members, calsyntenin-1, 2, 
and 3 share 70% amino acid identity. The protein family was named calsyntenin 
because of the acidic stretches in the cytoplamsic domain, consistent with a 
calcium binding function. Later, highly conserved homologues in human and 
mouse were also identified. The biological function of calsyntenin remains 
unknown but many of the properties that have been characterized provide clues for 
further investigation. The restricted localization in the CNS and the calcium binding 
motif in the cytoplasmic part of calsyntenin suggest its potential function in 
calcium buffering and signaling in neurons, which motivated our efforts to explore 
the roles of calsyntenin in calcium regulation in neurons and in excitotoxic 
neuronal cell death. 
 
Instead of the time-consuming generation of knockout animals, DNA 
vector-based siRNA was used in this project to achieve loss-of-function. RNA 
polymerase III promoters, which can produce small transcripts extending from a 
well-defined starting point to a 5T–in-row terminal, were isolated and cloned into 
vectors to conduct siRNA transcription. The siRNA template derived from a target 
gene sequence was cloned downstream to the promoter to produce siRNA 
transcripts that mimic intermediates in the RNA interference pathway and 
eventually induce sequence-dependent mRNA degradation. Using EGFP as a target 
gene, we demonstrated efficient and highly specific gene suppression by our 
vector-based siRNA system in the mammalian cell lines HEK293T and NG108-15. 
The co-transfected calsyntenin-1 expression was also strongly inhibited by 
introducing the corresponding siRNA construct pBlueU6-siCst1.1 in the NG-108 
cell line.  
 
Efficient gene delivery has proven difficult in neurons with electroporation and 
lipofectamine transfection. We have developed a solution involving the 
recombinant adeno-associate virus (rAAV) vector, which offers a promising tool to 
introduce foreign DNA into neurons in vitro and in vivo. Our rAAV carrying siRNA 
cassette against calsyntenin-1 transduced 90% of neurons in primary hippocampal 
neuronal culture under optimized conditions. Calsyntenin-1 suppression was 
evaluated with immunoblotting and immunocytochemistry, revealing a drastic 
calsyntenin-1 down-regulation by up to 60%.  Gain-of-function was achieved by 
introducing calsyntenin-1 over-expressing rAAV into neurons.  
 
The numbers of primary dendrites originating from neuronal soma and the 
secondary dendritic branches were counted in the calsyntenin-1 knockdown and 
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over-expressing neurons to screen for morphological changes in dendritic 
development. So far, no obvious changes were observed. To explore the potential 
involvement of calsyntenin in excitotoxicity, rAAV transduced neurons were 
exposed for 30 minutes to 100 µM NMDA to induce excitotoxic neuronal cell death. 
Nuclear condensation in apoptotic cells and apoptotic-like cells indicated by DAPI 
and Hoechst staining assays did not show significant differences in either 
calsyntenin-1 down-regulated or over-expressing cells.  
 
The preliminary data obtained from the calsyntenin-1 knockdown experiment is 
not sufficient to draw a conclusion whether calsyntenin plays a role in neuronal 
excitotoxicity. To exclude a compensatory effect by calsyntenin-2 and 3, a siRNA 
cassette targeting the common sequence shared between these two proteins was 
incorporated into the calsyntenin-1 knockdown vector. This approach makes the 
triple knockdown of all three calsyntenins possible. 
 
Further morphological investigations such as the analysis of total dendritic 
length and synaptic density will be conducted to give a more comprehensive 
understanding of the role of calsyntenins in neuronal development. Facilitated by 
the rAAV vehicle, calsyntenin suppression and over-expression in vivo can now be 
easily realized. Reversible focal cerebral ischemia induced by temporary middle 
cerebral artery occlusion may serve as a good model to answer the question 
whether the calsyntenins play a role in excitotoxic neuronal cell death.  
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Abbreviations 
 
 
Abbreviations  
AA 
AAV 
Aβ 
Ab 
AD 
acetyl-CoA 
AIF 
AMPA 
AP 
APP 
ATP 
bp 
BLAST 
BSA 
CA 
CaM 
CaMK 
cAMP 
caspase 
CCE 
CHS 
cDNA 
CNS 
cADPR 
Cst 
Cy3 
Cy5 
DAG 
DG 
dsRNA 
DMEM 
ECL 
EDTA 
ER 
FCS 
FGFR-1 
GFP 
Glu 
GluR 
Amino acid 
Adeno-associated virus 
β-amyloid 
Antibody 
Alzheimer’s Disease 
Acetyl-coenzyme A 
Apoptosis inducing factor  
A-amino-3hydroxy-5methyl-4-isoxazole-propionic acid 
Akaline phosphatase 
Amyloid precursor protein 
Adenosine triphosphate 
Base pair 
Basic Local Alignment Search Tool 
Bovine serum albumine  
Cornu ammonis 
Calmodulin 
Calmodulin-dependent protein kinase  
Cyclic adenosine monophosphate  
Cysteinyl-aspartate-cleaving protease 
Capacitive Ca2+ entry 
Chalcone synthase 
Complementary deoxyribonucleic acid 
Central nervous system 
Cyclic ADP ribose  
Calsyntenin 
Cytochrome-3 
Cytochrome-5 
Diacylglycerol  
Dentate gyrus; 
Double-stranded RNA 
Dulbecco/Vogt Modified Eagle's Minimal Essential Medium 
Enhanced electrochemiluminescence 
Ethylenediamine 
Endoplasmatic reticulum 
Fetal calf serum 
Fibroblast growth factor receptor 1 
Green fluorescent protein 
Glutamate 
Glutamate-specific receptor 
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HAT 
HBSS 
HEPES 
HEK293T 
HGFR 
HRP 
HSPG 
Ig 
Ins-1,4,5,-P3 
iGluRs 
ITRs 
KA 
kDa 
KLC 
MAPK 
mGluR 
miRNA 
mPTP 
mRNA 
NAADP 
NAD 
NADH 
NCBI 
NCS 
NMDA 
nt 
ORFs 
PART-1 
PAZ 
PBS 
PFA 
pH 
PLC 
PIWI 
PIP2 
PKC 
PMCA 
PNK 
PSD 
PVDF 
RBE 
RdRP/RDEs 
RE 
RISC 
Hypoxantine, Aminopterin,Thymidine) 
Hank’s balanced saline solution 
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
Human embryonic kidney 293 cell line 
Hepatocyte growth factor receptor  
Horse radish peroxidase 
Heparin sulfate proteoglican 
Immunoglobulin 
Inositol-1,4,5-trisphosphate 
Ionic glutamate-gated channels 
Inverted terminal repeats 
Kainic acid 
Kilodalton 
Kinesin light chain 
Mitogen-activated protein kinase  
Metabotropic glutamate receptor 
micro RNA 
Mitochondrial permeability transient pore  
Messenger ribonucleic acid 
Nicotinic acid dinucleotide phosphate  
Nicotinamid-adenine dinucleotide  
Nicotinamide adenine dinucleotide  
National Center for Biotechnology Information 
Newborn calf serum 
N-methyl-D-asparate 
Nucleotide(s) 
Open reading frames 
polyADP-ribose polymerase-1 
Piwi Argonaute Zwille 
Phosphate-buffered saline 
Paraformaldehyde 
pondus hydrogenii 
phospholipase C 
P-element induced wimpy testis 
Phospotidylinositol 4,5-bisphosphate 
Protein kinase C 
Plasma-membrane calcium-ATPase 
polynucleotide kinase 
Post-synaptic density 
Polyvinylidene Difluoride 
Rep-binding element 
RNA-dependent RNA polymerase  
Restriction endonuclease 
RNA-induced silencing complex 
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RLC 
RNase 
RNAi 
ROC 
ROS 
RyR 
RT 
SDS-PAGE 
SERCA 
SOCs 
siRNA 
shRNA 
TBS 
TBST 
TGS 
TKs 
Tris 
TRP 
Vg 
viRNA 
VOCs 
UTR 
RISC loading complex 
Ribonuclease 
RNA interference 
Receptor operated channel 
Reactive oxygen species 
Ryanodine  
Room temperature 
Sodium dodecyl polyacrylamide gel electrophoresis 
Sarcoendoplasmic reticular calcium ATPases 
Store-operated channels  
Small interfering RNA 
Short hairpin RNA 
Tris-buffered saline 
Tris-buffered saline Tween-20/Triton-X-100 
Transcriptional gene silencing 
tyrosine kinases  
Trishydroxymethylaminomethane-2-amino-2-hydroxymethyl-1,3-propanediol 
Transient receptor protein 
Vector genome 
Virus-derived siRNA 
Voltage-operated channels  
Untranslated region 
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II. Introduction 
 
2.1 Calsyntenin protein family 
 
In 2001, calsyntenin-1 was first discovered as a novel secreted protein by 
2-dimentional gel electrophoresis in the laboratory of Professor P. Sonderegger when the 
researchers screened for extracellularly cleaved proteins from supernatant of chicken 
spinal cord neurons growing in compartmentalized culturing system. The new protein 
shows apparent molecular mass of 115kD and pI value of approximate 6.0 in the 
2-dimentional gel analysis (Figure 2.1). Full cDNA sequence of the protein was 
subsequently revealed when searching available genomic database with cDNA fragment 
deduced from the 13 amino acids in the N-terminus by reverse genetics. Using the 
chicken calsyntenin-1 sequence, the homologues of this gene in mouse and human were 
identified by blast in corresponding genomes. Later, other two highly conserved members 
of calsyntenin family lately named calsyntenin-2 and calsyntenin-3 were discovered with 
the same approach from human and mouse genome databases. So far, three different 
genes encoding three calsyntenin members were found in mammals and avians but only 
one gene was revealed in C.elegans, D. melanogaster and D. rerio (Vogt et al., 2001). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.1: Calsyntenin-1 was identified from supernatant of compartmented 
cell culture by 2-dimentional gel electrophoresis (Vogt et al., 2001) 
A: Dissociated neurons from the ventral halves of E6 chicken spinal cords were seeded into the 
center compartment of compartmental culturing device. B: The neuritis extended to the side 
compartment after 6 days in culture. C: The compartmental cell culture system, in which the culture 
surface is subdivided into three compartments by a Teflon divider. D and E: Proteins released into 
the conditioned media of both the central and the side compartments were analyzed by 
two-dimensional SDS-PAGE and fluorography.   
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The open reading frame (ORF) of calsyntenin cDNAs flanked over approximate 
2900bp, encoding full length protein of roughly 140KD in molecular mass. The deduced 
protein sequences indicated that they are type I transmembrane proteins. According to 
two cadherin-like domains found in extracellular N-terminus, the proteins were considered 
belong to cadherin superfamily. The three members of calsyntenin family share 
high-degree homology on amino acid sequence of extracellular parts but distinct in their 
sequences of cytoplasmic domains.  
 
The cytoplasmic sequences of calsyntenin-1 and -2 are characterized with striking 
acidic amino acids clusters usually found in calcium-binding proteins, suggesting their 
potential calcium binding property. Later, in vitro calcium-overlay assay truly demonstrated 
the ability of calsyntenin-1 to bind calcium ions in a manner of low affinity but high capacity. 
Uniquely, calsyntenin-3 does not contain the acidic stretch in its relatively short 
C-terminus.  
 
In situ hybridization revealed that the calsyntenins are overwhelmingly expressed in 
CNS with distinct dominance in different subpopulation of neurons and in different brain 
regions. Calsyntenin-1 shows the strong expression in cortical neurons, pyramidal 
neurons and granule neurons in hippocampus, whereas the distribution of calsyntenin-2 
and -3 is confined to layer V and VI in cortex, CA2 and CA3 regions in hippocampus. In 
cerebellum, calsyntenin-1 was only found in granule cells while calsynenin-1 and -3 
exclusively present in Purkinjie cell layer (Hintsch et al., 2002) (Figure 2.2). 
Ph.D Thesis 
 
  14 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.2: Expression pattern of Calsyntenins in the adult mouse brain  
(Hintsch et al., 2002)  
A-C: In situ hybridization of coronal and horizontal whole-brain sections with DIG-labeled antisense riboprobe 
against calsyntenins show different expression pattern of the three calsyntenins in the neocortex (nc), the 
hippocampus formation (hc), the thalamus and the hypothalamus (ht). D-F: Localization of calsyntenin mRNAs 
in the hippocampus. Calsyntenin-1 is strongly expressed in all pyramidal cells of the CA1-CA3 regions, in the 
granule cells of the dentate gyrus and in some interneurons of all dendritic layers and hilus. Calsynetnin-2 and 
calsyntenin-3 expression is the strongest in CA2-CA3 pyramidal cells and subpopulations of interneurons in all 
compartments. Considerably lower levels of calsyntenin-2 and-3 mRNA are found in the CA1 region. G-I: Celluar 
localization of calsyntenin mRNAs in horizontal sections of the cerebellar cortex. Calsynternin-1 expression is 
strong in granule cell layer; no expression was detected in Purkinje cell layer. Low levels of calsyntenin-2 mRNA 
are restricted mainly to Purkinje cells. Calsyntenin-3 expression is very strong in Purkinje cells. 
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The full-length calsyntenins are located in postsynaptic densities by 
immunoelectromicroscopy using polyclonal antibodies generated by immunizing Rabbit 
with peptides derived from calsyntenins. When cleaved by unknown protease, 
calsyntenin-1 ectodomain is released into extracellular fluids and the calcium-binding 
transmembrane stump is internalized to the membrane of the spine apparatus, give rising 
to a speculation that the proteins may play roles in postsynaptic calcium buffering or 
signaling (Figure 2.3). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.3: Proposed mechanism of protease-dependent translocation of the 
postsynaptic Calsyntenin-1 (Vogt et al., 2001) 
Full-length calsyntenin-1 mainly located on postsynaptic membrane. After proteolytic cleavage by 
an extracellular protease in the synaptic cleft, the transmembrane stump is internalized into the 
membrane of the spine apparatus 
 
More hypothesis concerning functions of calsyntenins were raised according to 
recent observations in immunoprecipitation and yeast two-hybrid for screening their 
potential partners. When the yeast two-hybrid assay was performed with the bait derived 
from cytoplasmic domain of calsyntenin-1, a kinesin light chain (KLC) clone was isolated. 
Further pull down analysis confirmed that calsyntenin is highly associated with kinesin 
light chain which mediates microtubule-dependent transportation, suggesting the 
calsyntenins may be involved in the cargo vesicle delivery in neuron. The KLC-binding 
sites were clearly revealed by mapping with a serial of deletion mutants (Konecna et al., 
2006). 
 
Additionally, calsyntenin-1 was identified as a binding partner to X11L/Mint2 and 
amyloid-beta precursor protein (APP) in the yeast two-hybrid screen by a group of 
Japanese scientists. The immunopercipitation assay resulted in stable tripartite complex 
consisting of APP, X11L/Mint2 and calsyntenin-1, which is coincident to previous founding. 
X11L/Mint2 is known as an adaptor protein to APP which stabilizes the full-length APP on 
the cell membrane by suppressing APP metabolism to a reduced amyloid-beta generation. 
Calsyntenin-1, sharing the similar binding motif of APP to X11L/Mint2, demonstrated an 
enhanced stabilization of APP in the in vitro co-expression assays (Araki et al., 2003). 
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Since the extracellular senile plaques comprised mainly by amyloid-beta represent a 
critical pathologic feature of neurodegenerative Alzheimer’s Disease (AD), APP/ 
amyloid-beta processing and molecular mechanisms underlying intracellular trafficking of 
APP become very important to understand AD pathogenesis. The APP/ amyloid-beta 
metabolism is a strictly regulated process and the disturbance has vital impacts on the 
amyloid-beta accumulation leading to AD. Based on this knowledge and the possible 
involvement of calsynenin-1 in APP metabolism, the protein was named differently as 
Alcadein (Alzheimer-related cadherin-like protein) by the Japanese scientists. 
 
Among all the properties of calsyntenins which have been revealed, the translocation and 
internalization of putative calcium-binding stump after extracellular cleavage draw our 
attention to explore their potential roles in calcium buffering or signaling which may be 
further linked to neuronal excitotoxicity. 
 
2.2 Calcium signaling and Excitotoxicity 
2.2.1 Calcium and calcium signaling 
As the most ubiquitous and versatile intracellular modulator, free cytosolic calcium ion 
(Ca2+) impacts nearly entire aspect of cellular physiology by playing vital roles in cell 
signaling pathways. The common mechanism behind calcium signaling is to convert a 
variety of external signals that do not cross the plasma membrane into numerous 
intracellular calcium-sensitive processes by generating temporally and spatially controlled 
pulses of free cytosolic calcium. For this purpose, cells exploit broad group of pumps, 
channels, transporters and Ca2+ binding proteins to achieve the fine tune of Ca2+ signals 
(Clapham, 2007). 
Most of the cellular Ca2+ ions are isolated from cytoplasm by intracellular 
compartments. Endoplasmic reticulum (ER) is generally the predominant intracellular 
Ca2+ store where Ca2+ are bound to high capacity-low affinity Ca2+ buffering proteins such 
as calsequestrin and calreticulin. There are many other proteins in the cytoplasm and 
other organelles such as mitochondria act as Ca2+ buffers by transiently binding to Ca2+. 
The level of free cytosolic Ca2+ is normally maintained to resting concentration at a low 
range of 10-100nM through the combined actions of a number of buffering proteins and 
Ca2+ compartmentalization mechanisms. Cytosolic Ca2+ increases to active level of 
roughly 1000nM as a result of either Ca2+ uptake from extracellular environment or the 
release from intracellular stores through certain calcium channels. The stimuli binding on 
the receptors turn on the ON mechanism to activate those channels and finally trigger the 
Ca2+ signaling by generating various Ca2+ mobilizing signals to feed Ca2+ into cytoplasm.  
There are many proteins identified as Ca2+ entry channels on the plasma membrane 
for delivering Ca2+ from external medium in response to stimuli including membrane 
depolarization, extracellular agonists or intracellular messengers. Those channels were 
traditionally classified into three groups according to the ways how they are activated: 
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voltage-operated channels opening in response of voltage change, receptor-operated 
channels opening upon binding with external stimuli, and store-operated channels 
opening in response to depletion of internal Ca2+ stores (Berridge et al., 2003). 
The release of Ca2+ from the intracellular stores is controlled by Ca2+ itself or by a 
group of Ca2+ mobilizing messengers, such as inositol-1,4,5-trisphosphate (Ins-1,4,5,-P3), 
ryanodine (RyR), cyclic ADP ribose (cADPR) and nicotinic acid dinucleotide phosphate 
(NAADP). The formation of Ins-1,4,5,-P3 is a focal point of major signaling pathways, one 
is initiated by a family of cell surface receptors, G protein-coupled receptors and the other 
is triggered by receptors linked with tyrosine kinases (TKs) either directly or indirectly. 
When activated by stimulus, those receptors are coupled to energy-dependent 
transducing mechanisms which activate phospholipase C (PLC) enzymes to generate 
inositol-1,4,5-trisphosphate (Ins-1,4,5,-P3) and diacylglycerol (DAG) by hydrolyzing 
phosphotidylinositol 4,5-bisphosphate (PIP2). Ins-1,4,5,-P3 then bind to ER channel 
inositol-1,4,5-trisphosphate receptor (InsP3R) to enable the releases of stored Ca2+ from 
ER, thus to promote a increase in free cytoplasmic Ca2+concentration. Other Ca2+ 
mobilizing messengers like cyclic ADP ribose (cADPR) and nicotinic acid dinucleotide 
phosphate (NAADP) generated from nicotinamid-adenine dinucleotide (NAD) modulate 
Ca2+ release from ER through different mechanisms. The Ca2+ released to cytoplasm 
activates a wide range of Ca2+ sensors and Ca2+-sensitive processes, thus initiate 
different cytoplasmic and nuclear actions which finally lead to divergent cellular processes 
such as membrane excitability, metabolism, vesicle trafficking, gene transcription or cell 
proliferation and fertilization (Clapham, 1995, , 2007) (Figure 2.4). 
 
Figure 2.4: Ca2+ signaling network (Berridge et al., 2000) 
Cells have an extensive signaling toolkit that can be mixed and matched to create Ca2+ signals of 
widely different properties. BLUE: Ca2+-mobilizing signals generated by stimuli acting through a 
variety of cell-surface receptors(R). GREEN: ON mechanisms that respond to transmitters or the 
Ca2+-mobilizing signals, leading to the Ca2+ influx into cytoplasm. PURPLE: Ca2+ sensors 
activated by ON mechanisms, allowing the activation of a wide range of Ca2+ sensitive processes.  
RED: OFF mechanisms that pump Ca2+ out of cytoplasm. 
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Upon entering into cytosol, only very small portion of Ca2+ end up being free since 
most of them rapidly bind either to Ca2+ buffering proteins such as calretinin, calbindin and 
parvalbumin, or to Ca2+ sensors and effectors such as calmodulin and Ca2+-sensitive 
enzymes. So far over 200 Ca2+-binding proteins have been identified as Ca2+-buffering 
proteins or effectors in human genome. The buffering proteins function as the spatial and 
temporal fine-tunes to Ca2+ signaling by chelating and releasing Ca2+ in different Ca2+ 
levels to alter the amplitude or duration of individual Ca2+ signals. Ca2+ buffering proteins 
such as parvalbuin and calbindin exist in high concentration in neurons that enable the 
confined and localized Ca2+ signaling in synapses. The most common motif shared within 
the Ca2+ binding proteins is the EF hand helix-turn-helix in which seven negatively 
charged oxygen atoms cage Ca2+ tightly. The EF-hand Ca2+ binding proteins can be 
divided into two classes: signaling proteins and buffering proteins. The former one 
typically undergoes a conformational change upon the Ca2+ binding to open a binding site 
for target proteins, while the latter one is represented by calbindin D9k which does not 
undergo calcium dependent conformational changes (Burgoyne and Weiss, 2001). 
 
Some of the Ca2+ binding proteins such as troponin C and calmodulin (CaM) play vital 
roles as sensor or adaptor that converts Ca2+ signals to protein interaction. The small 
acidic protein Calmodulin (CaM) ubiquitously expressed in all eukaryotic cells is the most 
extensively studied Ca2+ signaling protein. Since it contains four EF-hand motifs, each 
calmodulin molecule could bind up to four Ca2+, offering a diversified capacity to Ca2+. 
Additionally, the post-translational modifications such as phosphorylation, acetylation, 
methylation and proteolytic cleavage could modulate the calcium binding properties of 
calmodulin and subsequently further diversify its actions. By undergoing pronounced 
conformational change upon Ca2+ binding, the hydrophobic groups from inner residues 
are exposed to the surface of calmodulin protein which consequently allows the 
interaction with the complementary hydrophobic region on different protein targets. 
Through activating a wide range of targets, Calmodulin (CaM) orchestrates 
comprehensive cellular responses to cell excitation resulting from the simple elevation of 
intercellular Ca2+ concentration. The calmodulin (CaM) is used as a Ca2+ signal transducer 
in those processes since most of the protein targets that the calmodulin binds to are not 
able to interact with Ca2+ directly. The calmodulin also extends the reach of Ca2+ by 
activating a number of different Ca2+-regulated enzymes and pathways, such as 
phosphorylation pathways, protein kinase C (PKC), cyclic AMP phospodiesterase, 
Ca2+-activated proteases (calpains) and Ca2+/calmodulin-dependent protein kinases 
(CaMK). Those calcium-sensitive effectors finally allow different cellular actions including 
gene transcription, channel activity, metabolism, proliferation and differentiation (Ivings et 
al., 2002). In addition to the general modulator like calmodulin, there are many other Ca2+ 
binding proteins engaged in specific functions, such as Ca2+ sensor synaptotagmin which 
is fully specified for exocytosis of membrane vesicles in synapses. 
2.2.2 Calcium Homeostasis 
Calcium homeostasis refers to the regulation of the concentration of calcium ions in 
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cytoplasm. The disturbed intracellular calcium homeostasis causes general metabolic 
dysfunction eventually leading to cell death. Through combined action of pumps and 
exchangers, Ca2+ level is controlled by the “on” reaction that introduce Ca2+ into 
cytoplasm between the “off” reactions that remove the Ca2+ signal from cytoplasm. Influx 
and efflux of cytosolic Ca2+ during the ON and OFF reactions should be balanced to avoid 
the net loss or gain of cytosolic Ca2+. Ca2+ could be turned to toxic signals when delivered 
in wrong level, wrong time and wrong place.  
 
Entry of extracelluar Ca2+ is driven by various channels that open either in response 
to different external signals or in the presence of a large electrochemical gradient across 
the plasma membrane as described before. NMDA (N-methyl-D-aspartete) receptor which 
belongs to receptor-operated channel (ROC) induces Ca2+ entry in response to glutamate 
binding. The voltage-operated channels (VOCs) in excitable cells generate the rapid Ca2+ 
influxes inducing fast cellular process such as muscle contraction or exocytosis at 
synaptic cleft. There also are many other channel types that are sensitive to a diverse 
array of stimuli, such as cyclic-nucleotide-gated channel and arachidonic-acid-sensitive 
channel which represent second-messenger-operated channels controlled by internal 
messengers, and the store-operated channels, thermosensor or stretch-activated 
channels that belong to the board transient receptor protein (TRP) ion-channel family. 
Members of TRP channels are particularly important in controlling slow cellular processes 
such as cell proliferation since they share the common property of slow conductance and 
therefore operated over longer time scales to drain Ca2+ into the cells.  
 
Once Ca2+ has carried out its signaling function, it should be rapidly removed from the 
cytoplasm. Although the plasma-membrane Ca2+-ATPase (PMCA) pump and Na+/ Ca2+ 
exchanger (NCX) are responsible for driving the extrusion of Ca2+ from the cells, the 
maintenance of the cytoplasmic Ca2+ homeostasis mainly relies on sequestering Ca2+ with 
intracellular compartments and buffering with specific calcium binding proteins. To 
maintain Ca2+ in the low resting concentration in cytoplasm, Ca2+ is actively and constantly 
translocated into ER and sometimes into mitochondria through the action of 
sarcoendoplasmic reticular calcium ATPases (SERCA) and mitochondrial uniporter 
respectively (Berridge et al., 2000).  
 
Ca2+ sometimes acts to control Ca2+ management within cell as a feedback 
mechanism such as capacitive Ca2+ entry (CCE) which modulates Ca2+ influx through 
store-operated channels (SOCs) activated by depletion of intracellular Ca2+ stores. 
Additionally, passive Ca2+ release from ER is dependent on ER lumenal Ca2+ level with 
the evidence that low ER Ca2+ concentration greatly reduces the leakage. Ca2+ level in ER 
lumen can even affect the IP3R and SERCA activities during Ca2+ translocation (Bano and 
Nicotera, 2007). 
2.2.3 Calcium signaling in Neuron  
Basically, neuron shares the same Ca2+ signaling mechanism with other different cell 
types. Through numerous calcium-regulated pathways, Ca2+ signals govern most, if not all 
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of cellular activities in neuron such as neurotransmission, synaptic activity, plasticity, 
potentiation, growth and gene expression. Since that, neurons must maintain the Ca2+ 
homeostasis in a tightly controlled manner to ensure the efficient signaling. The resting 
Ca2+ concentration is balanced at a low level of approximately 100nM to enable the high 
signal-to-noise ratio so that small increase in Ca2+ concentration is sufficient to trigger 
physiological actions. Therefore, delicate and complex mechanisms have been evolved in 
neurons to orchestrate Ca2+ influx, Ca2+ buffering, Ca2+ storage and Ca2+ efflux for 
maintaining cytosolic free Ca2+ homeostasis (Arundine and Tymianski, 2003). 
 
The diversity of neuronal cell functions controlled by Ca2+ results from distinct types 
of Ca2+ signaling that differ in spatial and temporal aspects. Except for general Ca2+ 
sensor proteins such as calmodulin, a number of other Ca2+ binding proteins such as 
neuronal calcium sensor protein (NCS) family are either exclusively expressed or 
enriched in the nervous system, where they have distinct roles in regulating neuronal 
functions. Members of NCS protein family share similar compact globular structure in 
which four EF-hand motifs are present for Ca2+ binding while they show big differences in 
Ca2+ affinity, Ca2+ binding dynamics, subcellular localization, targets and expression 
patterns which contribute vast diversity of the functions of this protein family. These NCS 
proteins have been implicated in a group of Ca2+ signaling related events such as 
neurotransmitter release, channel and receptor regulation, neuronal growth, survival and 
gene transcription (Haeseleer et al., 2002; Burgoyne, 2007). Neurons have several Ca2+ 
sensitive pathways located in different regions. In the synaptic ending, membrane 
depolarization produces a localized pulse of Ca2+ that triggers exocytosis, whereas in the 
cell body and dendrites, the same depolarization can induce Ca2+ entry to activate a 
number of targets such as adenylyl cyclase, mitogen-activated protein kinase (MAPK) and 
Ca2+/calmodulin-dependent protein kinase (CaMK).   
2.2.4 Calcium-dependent excitotoxicity 
Nerve cell damage induced by excessive glutamate load was initially described as 
excitotoxicity by Olney in 1969. Over the years, the mechanism of excitotoxicity is 
formulated stepwise by intensive and extensive studies. Briefly, excitotoxicity refers the 
over-activation of postsynaptic excitatory neurotransmitter receptors induced by excessive 
synaptic release of glutamate or other excitotoxins, which allows the massive influx of 
calcium ions into the neuron and consequently leads to the disturbed regulation of 
calcium-dependent enzymes and signaling cascades which eventually cause neuronal 
cell death (Sattler and Tymianski, 2000). 
 
Excitotoxicity is believed to be major mechanism contributing to neurodegeneration in 
many central nervous system diseases such as ischemia, stroke, Multiple sclerosis, 
Alzheimer’s disease, Pakinson’s disease and Huntington’s disease. The failure in the 
clearance of excessive excitatory transmitter causes sustained gating of 
receptor-operated channels, leading to prolonged neuronal depolarization and excessive 
Ca2+ load. As the major excitatory neurotransmitter in mammalian, glutamate mediates 
most of the excitatory neurotransmissions and also plays a vital role as prime excitotoxin 
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in the excitotoxic neuronal cell death (Bano and Nicotera, 2007).  
 
Glutamate receptors are categorized into two distinct classes of ligand gated ion 
channels (ionotropic glutamate recepters) and G-protein coupled receptors (metabotropic 
receptors) based on their prototypic pharmacological agonists. The former could be 
further subdivided into three groups: AMPA, NMDA and kainite receptors, according to 
their pharmacology structural similarities; whereas the latter are subdivided into three 
groups: Group I, Group II and Group III, according to their sequence similarities, 
pharmacology and intracellular signaling mechanisms. The neurotransmitter glutamate 
generates Ca2+ signals either by activating receptor-operated channels such as NMDA 
receptor, or by stimulating the metabotropic glutamate receptor mGluR to produce 
Ins(1,4,5)P3 to mobilize internal Ca2+ from the endoplasmic reticulum (ER). Although most 
of glutamate receptor subtypes involve in mediating excitotoxic neuronal cell death, 
NMDA receptors play the most critical role because of their high permeability to Ca2+. Due 
to a voltage-dependent block of the channel pore by magnesium ions, NMDA receptors 
are inactive at resting membrane potentials. The impulses generated by sustained 
activation of other receptors such as AMPA receptor could depolarize the postsynaptic 
membrane to release the channel block of NMDA receptors and thus allowing Ca2+ influx 
into the postsynaptic cells. Under certain conditions like prolonged depolarization, the 
magnesium block may be completely removed, leading to massive influx of Ca2+. Group I 
mGluR coupled to PLC through G-protein is also involved in Ca2+ signaling since its 
activation leads to an increase in IP3 production which mediate intracellular Ca2+ signaling 
by inducing Ca2+ release from ER to cytoplasm. Group II and group III receptors are 
negatively coupled to adenylyl cyclase through G protein. When those receptors are 
over-stimulated, the production of an important Ca2+ regulator cAMP will be inhibited, 
leading to a interrupted Ca2+ signaling (Berliocchi et al., 2005). 
 
In pathological condition, excessive Ca2+ entry through NMDA receptor and other 
channels causes the excitotoxic Ca2+ overload exceeding the capacity of regulatory 
mechanism, triggering abnormal activation of Ca2+–sensitive processes. For instance, 
excessive Ca2+ in cytosol could result in protease calpain activation, which leads to 
general proteolysis of proteins in the cytoskeleton, ion channels, enzymes, cell surface 
receptors and consequent irreversible cell damage. Other calcium-dependent enzymes 
such as endonucleases, ATPase and phospholipases are also involved in the process of 
excitotoxicity when they are over-activated. The transcription factors such as c-Fos, c-Jun 
and c-Myc are induced, leading to transcriptional activation of certain genes involved in 
cell death. Additionally, cells overexcited by excess Ca2+ accumulate toxic free radicals 
such as superoxide and nitric oxide participated in unwanted side reactions, resulting in 
cell damage. For example, the activation of neuronal nitric oxide synthase leads to DNA 
damage by over-production of nitric oxide and peroxynitrite (Dawson and Dawson, 1998). 
PARP-1 activation triggers the release of the apoptosis inducing factor (AIF) from 
mitochondrial membranes, which participates in large-scale DNA fragmentation. (Susin et 
al., 1999) In turn, the disrupted plasma membrane and ion channels allow the 
uncontrolled influx of Ca2+ into the cell, which ultimately leads to an irreversible buildup of 
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the intracellular Ca2+ concentration. All these mechanisms lead to cell death through 
necrosis or apoptosis (Arundine and Tymianski, 2003)(Figure 2.5). 
 
 
Figure 2.5: proposed mechanisms of Ca2+-dependent excitotoxicity (Sattler and 
Tymianski, 2000) 
This is a schematic and descriptive presentation of proposed mechanisms by which intracellular 
Ca2+ elevation may trigger secondary Ca2+ dependent phenomena, which result in neurotoxicity. 
NO: Nitric oxide; ONOO: peroxynitrite; ATP: adenosine triphosphate; ADP: adenosine diphosphate; 
DNA: desoxyribonucleic acid. 
 
Mitochondria are usually described as "power plants" because they generate most of 
the cell's supply of adenosine triphosphate (ATP) as a source of chemical energy. But in 
pathological condition, mitochondria are thought to be the target organelles of Ca2+ 
dependent excitotoxic processes. It has been known for long time that the mitochondria 
are capable of accumulating Ca2+ but its importance as intracellular Ca2+ store was 
considered as minimal since mitochondrial Ca2+ uptake mechanism is not related to 
physiological increases in cytosolic Ca2+. Mitochondria Ca2+ is regulated by fundamentally 
distinct mechanisms that differ from those used in ER. Primarily, mitochondria take up 
Ca2+ rapidly through the mitochondrial uniporter driven by membrane potential. 
Mitochondrial Ca2+ is balanced by Ca2+ extrusion through mitochondrial Na+/ Ca2+ 
exchanger in cardiomyocytes and neurons, and through H+/Ca2+ exchanger in 
hepatocytes (Montero et al., 2001). Another mechanism involved in Ca2+ efflux is the 
formation and opening of mitochondrial permeability transient pore (mPTP) when factors 
such as mitochondrial membrane depolarization or oxidized NAD/NADP and superoxide 
anions were accumulated. The prolonged opening of mPTP triggers a rapid excessive 
release of Ca2+ and mitochondrial metabolites including apoptotic factors such as 
cytochrome C. The excessive cytosolic Ca2+ accumulation results in subsequent 
abnormal increase of Ca2+ in mitochondria lumen, demonstrating a synchrony between 
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[Ca2+]i and [Ca2+]mt oscillations (Hajnoczky et al., 1995) (Won et al., 2002). 
 
The mitochondria become the focal point of Ca2+ dependent excitotoxic processes 
since the dysfunction of mitochondrial Ca2+ regulation causes Ca2+ accumulation in 
mitochondria and subsequently disturb ATP synthesis due to the collapse of mitochondrial 
electron transportation and oxidative phosphorylation. The activation of many key 
mitochondrial enzymes involved in ATP production, such as puruvate dehydrogenase and 
NAD-isocitrate dehydrogenase, are related to Ca2+ concentration. The ATP production 
could be stopped unexpectedly when the Ca2+ regulation goes wrong in mitochondria. 
(McCormack et al., 1990) ATP is the main energy source for the majority of cellular 
functions. In glutamate excitotoxicity, the inadequate ATP first eliminates electrochemical 
gradients of certain ions required for removing glutamate from the extracellular space. 
Additionally, ATP-dependent ion transporters fail, leading to cell depolarization and 
allowing Ca2+ to flow into the cell. Cell membranes are disrupted by activated 
phospolipases, allowing more ions and toxic chemicals flow into the cell. Ion pumps fail to 
transport Ca2+ out of the cell, amplifying the accumulation of Ca2+ which triggers the 
release of excitatory amino acid neurotransmitter glutamate. This results in a buildup of 
glutamate and further damaging activation of glutamate receptors on the postsynaptic 
membrane. The glutamate stimulates both Ca2+-permeable AMPA receptors and NMDA 
receptors to allow more Ca2+ influx into cytoplasm. During the excessive Ca2+ entry, 
mitochondria metabolism has been damaged, causing increased reactive oxygen species 
(ROS) production and the initiation of caspase-dependent apoptosis cascade. Finally, 
mitochondria are swelling and even broken down to release proteins that can lead to cell 
death into cytoplasm (Arundine and Tymianski, 2003). 
 
 
2.3 RNA interference (RNAi) 
 
RNA interference (RNAi) is evolutionarily mechanism that hinders specific gene 
expression by causing homology-dependent RNA degradation, which represents a 
protective mechanism to combat the invasion from virus and genetic parasites.  
 
The phenomenon was first observed in plant petunias in 1990 by Rich Jorgensen and 
his colleagues when they attempted to overexpress pigment-producing chalcone 
synthase (CHS) in petunia petals by introducing chimeric petunia CHS gene into the plant. 
Surprisingly, instead of expected dark violet color, most of the flowers appeared 
unpigmented white or variegated. RNase protection analysis showed that the mRNA level 
of both introduced and endogenouse CHS genes were reduced drastically. They termed 
this bizarre phenomenon as “co-suppression” of homologous genes, but the mechanism 
behind remained unclear (Napoli et al., 1990). 
 
Soon after, similar observation was noted in a wide range of organisms. In 
filamentous fungi Neurospora crassa, introduction of exogenous sequences derived from 
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carotenogenic albino-3 (al-3) and albino-1 (al-1) genes provoked a severe impairment in 
the expression of the endogenous al-1 or al-3 genes, leading to an wild-type or 
intermediate phenotype, which is termed as “quelling” (Romano and Macino, 1992). In 
Drosophila, rather than the expected gene dosage effect, the expression of Alcohol 
dehydrogenase (Adh) gene is progressively reduced both in larvae and adults by the 
introduction of promoter-Adh fusion gene, which is strongly analogous to "co-suppression" 
phenomena described in plant species (Pal-Bhadra et al., 1997). 
 
For a long time, the “co-suppression” and the “quelling” were considered as a simple 
antisense-mediated silencing mechanism depending on hybridization between 
homologous RNA transcripts since many evidences indicated that the suppression 
occurred post-transcriptionally (J.M. Kooter et al. 1994). Based on this hypothesis, in 1995, 
Guo and Kamphues first make attempt to use the artificial RNA fragment to shutdown 
gene expression in nematode worm Caenorhabditis elegans. They demonstrated a 
successful blocking of par-1 gene expression with the RNA fragments complementary to 
par-1 mRNA. But, surprisingly, they found that the sense RNA fragment could also 
provoke target gene silencing, challenging the proposed antisense-mediated silencing 
mechanism since the sense RNA can not pair with the mRNA to block the translation (Guo 
and Kemphues, 1995).  
 
The phenomenon remains mysterious until the study of the similarity between natural 
viral-induced and transgene-induced gene silencing in plants reveals that viral defense 
and RNA-induced posttranscriptional gene silencing (PTGS) may share a common innate 
biological mechanism, suggesting the homology-dependent gene silencing may represent 
an evolved RNA-mediated antiviral response mechanism in the organisms (Frank Ratcliff, 
et al. 1997). In 1998, Andrew Fire reported that double-stranded RNA (dsRNA) was 
substantially more effective at triggering potent and specific gene silencing than either 
strand does individually in Caenorhabditis elegans. A few molecules of the dsRNA could 
achieve pronounced decrease or elimination of endogenous gene expression in affected 
cell, while extensively purified antisense and sense RNAs had only marginal interference 
activity even injected in high dose. Additionally, they found that the silencing effect of 
dsRNA could be passed through germ line cells to progeny for several generations (Fire et 
al., 1998). Those features further argue against the previous hypothesis that the 
interference relies on stochiometric binding between introduced RNA and endogenous 
mRNA.  
 
Fire and his colleagues termed the phenomenon as RNA interference (RNAi) to differ 
it from the passive antisense RNA silencing. They proposed that exogenous dsRNAs act 
as initiators in RNAi process, activating unknown cellular mechanisms of signal 
amplification and sequence-specific RNA degradation when they were introduced into cell. 
This explanation adds on an entirely new understanding of gene regulation and offers 
possibility to develop a potent approach for achieving loss-of-function to determine the 
role of gene by depleting specific mRNA with synthetic dsRNAs. Since that, RNAi became 
one of the most exciting biological discoveries, calling on extensively studies for 
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mechanistic base behind it. 
 
RNAi has since been discovered in most eukaryotic organisms. In addition to its 
biological roles in protecting the genome against RNA invasion and instability caused by 
transposons (Ketting et al., 1999), RNAi was proved involved in developmental gene 
regulation and genome maintenance since the disruption of genes required for RNAi 
causes several developmental defects (Bernstein et al., 2001a). A group of 21-23 
nucleotide RNA molecules encoded in genomes were identified as microRNAs (miRNAs) 
from eukaryotic cells emerging as important endogenous RNAi modulators in cellular 
pathways such as growth and proliferation, apoptosis, and developmental timing (Ruvkun, 
G. 2001).  
 
Artificial dsRNA has long been used for eliminate specific gene expression in many 
organisms. Following the observation of synthetic short RNA mediated the 
sequence-specific mRNA degradation in mammalian cells in 2001, small interfering 
RNA(siRNA) was immediately developed as a potential therapeutic strategy for silencing 
 disease-related genes (Elbashir et al., 2001). Since Fire and Mello first clearly 
elucidated the silencing trigger and established the fundamental understanding to RNAi 
mechanism, they were eventually awarded Nobel Prize in Physiololgy or Medicine in 2006 
for the great discovery of RNAi. 
 
2.3.1 Mechanism of RNAi in post-transcriptional gene silencing 
Some components required in the RNAi network were first identified by genetic 
screening in some C. elegans mutants which resistant to dsRNA-mediated RNA 
interference (Tabara et al., 1999). The protein encoded by one of RNAi-resistant genes 
shares homology to RNase D, supporting the idea that RNAi is dsRNA-directed enzymatic 
RNA degradation (Ketting et al., 1999). Soon after, when the RNAi was examined in the in 
vitro system derived from Drosophila S2 cells, it was discovered that the introduced 
dsRNAs were processed to segments in 21-23 nucleotides in length during the RNAi 
reaction. Cleavage of target mRNA occurs at homologous sites sharing same 21-23 
nucleotides cleavage interval observed for the dsRNA trigger itself, suggesting that the 
21-23 nucleotide fragments cleaved from the dsRNA are guiding mRNA cleavage 
(Zamore et al., 2000). Chemically synthesized 21nt RNA fragments targeting firefly 
luciferase gene show efficient target mRNA cleavage in the Drosophila in vitro system, 
leading to the conclusion that 21-23 nucleotides small interfering RNA (siRNA) is indeed 
the mediator of sequence-specific mRNA degradation (Elbashir et al., 2001).  
In 2001, the enzyme responsible for producing siRNA was identified as Dicer, an 
evolutionary conserved member of RNase III family of nucleases that specifically cleave 
dsRNA. It also revealed that the cleavage of target mRNA was conducted independently 
by RNA-induced silencing complex (RISC) in which the Argonaute proteins may play the 
role in mRNA slicing. Thus, the RNAi pathway was divided conceptually into initiation 
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phase in which the dsRNA trigger was converted into siRNA, and effectors phase in which 
mature RISC mediated cleavage of target mRNA (Bernstein et al., 2001b).  
Piece by piece, the puzzle of RNAi mechanism was assembled rapidly. The current 
model of RNAi implies that the RNAi pathways are initiated by the enzyme Dicer, which 
processes exogenous dsRNA or endogenous pre-miRNA into 21-23 nucleotides siRNA 
and miRNA respectively. One of strands from siRNA or the unwinding miRNA paired with 
complementary sequences of target mRNA and incorporated into RISC. The catalytic 
components of RISC complex finally conducted the mRNA degradation, leading to the 
post-transcriptional gene silencing (Figure 2.6). 
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Figure 2.6: Outline of RNAi Mechanism in mammalian cell (From 
www.mirusbio.com) 
The RNAi pathways are initiated by the enzyme Dicer, which processes exogenous dsRNA or 
endogenous pre-miRNA into 21-23 nucleotides siRNA and miRNA respectively. One of strands from 
siRNA or the unwinding miRNA paired with complementary sequences of target mRNA and 
incorporated into RISC. The catalytic components of RISC complex conducted the mRNA 
degradation, leading to the post-transcriptional gene silencing.
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2.3.1.1 Initiation phase: processing of RNA triggers 
It is clearly known that dsRNA plays a very important role in RNAi pathway not only 
as silencing trigger but also as an intermediate. Silencing triggers in the form of dsRNA 
may be presented in the cells as synthetic RNA, RNA viruses or transcripts copied from 
aberrant mRNA from nuclear genes by RNA-dependent RNA polymerase (RdRP or 
RDEs). Upon entering into cytoplasm, those dsRNA triggers were recognized and 
processed to discrete sizes of ~25 nucleotides by Dicer, a ~200 kDa highly conserved 
RNase III family containing two catalytic RNase III domains, Piwi Argonaute Zwille (PAZ) 
motifs and RNA helicase. Biochemical analysis revealed that the Dicer functions as 
dimeric complex in which two enzymes aligned in antiparallel manner, giving rise to 
unique structure with two active compound catalytic centers consisting of RNase III 
domains from both monomers. When recognized and captured by PAZ motifs of the Dicer, 
dsRNA substances were then successively cleaved in certain interval by the dual catalytic 
domains, producing precisely sized siRNA fragments. (Hannon, 2002) The cutting interval 
is determined by the spacing of the two catalytic centres within the Dicer. That 
characteristic feature of Dicer offers a good explanation to the species-specific variation in 
siRNA length (Figure 2.7). 
 
Figure 2.7: Diagrammatic representation of Dicer binding and cleaving dsRNA 
(Hannon, 2002) 
Two separate Dicer molecules are colored differently. Deviations from the consensus RNase III 
active sites in the second RNase III domain inactivate the central catalytic sites, resulting in target 
mRNA cleavage at 22-nucleotide intervals. 
Primary miRNA (pri-miRNA) transcripts containing imperfect stem-loop pairing 
structure are first processed by Drosha within nucleus. The resulting precursor miRNA 
(pre-miRNA) are then exported into cytoplasm to enter RNAi pathway. In Drosophila, 
miRNA and siRNA are produced by distinct Dicers, whereas in vertebrates both miRNA 
and siRNA are produced by the only one Dicer. 
2.3.1.2 Effector phase: RISC assembly and mRNA degradation 
The resulting siRNA duplexes from the Dicer cleavage shared a common 
configuration of phosphorylated 5’ termini and 3’ overhang with two nucleotides, which 
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have been proven functionally important for incorporation to nuclease to form 
RNA-induced silencing complex (RISC).  
Although the mechanism of mRNA cleavage is not fully revealed, the responsible 
RNase has been identified to be distinct from Dicer. To find out the “slicer”, RISC was 
isolated through co-immunopercipation with biotin-conjugated siRNA for further 
evaluation .The biochemical studies elucidate that the RISC is a multiprotein complex of 
500kDa, mainly containing siRNA and Argonaute family proteins which have been 
implicated in RNAi pathways in screens of RNAi-deficient mutants. Family members of 
Argonaute share two characteristic domains: PAZ which was also found in Dicer, and 
PIWI (P-element induced wimpy testis) which is unique to this protein family. The 
Argonaute family can be divided into Ago subclass and Piwi subclass according to their 
functions and distributions. Ago proteins are ubiquitously expressed whereas Piwi 
proteins are restricted to germ line cells. X-ray crystallography reveals that the PIWI 
domain within Ago protein isolated from archaeal shares remarkable similarity to the 
RNase H enzymes on the secondary structure, indicating its potential role as mRNA slicer 
in RISC (Song et al., 2004). Further biochemical conducted with the immunopercipitated 
Ago complexes from human 293T cells show that one of Ago (Ago2) indeed performs 
endonucleolytic cleavage on mRNA in RNAi pathway (Liu et al., 2004). 
In mammalian cells, the core component of RISC loading complex (RLC) consisting 
of Dicer (Dcr-2) and R2D2 heterodimer binds to the 2-nucleotide overhangs of siRNA 3’ 
end. Then the key RISC component Ago2 displaces Dcr-2/R2D2 heterodimer in 
ATP-dependent manner to form mature RISC. Ago2 is also responsible for unwinding of 
the siRNA duplex, which removes the passenger strand and incorporates the remained 
guide strands into RISC. Active RISC containing only guide strand performs mRNA 
cleavage by the endonuleolytic PIWI domain of Ago protein. It is believed that the PIWI 
motif of Ago recognizes and anchors the 5’ phosphorylated end of siRNA guide strand, 
while the PAZ domain offers a binding pocket to characteristic 3’ end of siRNA, allowing 
the rest of guide siRNA to pair to complementary site of target mRNA which were also 
incorporated by PIWI domain (Matranga et al., 2005; Rand et al., 2005) (Figure 2.8). 
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Figure 2.8: RISC Assemble and mRNA Cleavage (Ambion) 
This is a general summary of current thinking about assembly of siRNA with RISC and mRNA 
cleavage activity. Only core components of the RISC loading complex (RLC) and RISC are depicted. 
RLC contains a Dcr-2/R2D2 heterodimer which binds the siRNA containing dinucleotide 3’ 
overhangs. Core RISC component Ago2 displaces Dcr-2/R2D2. Duplex siRNA transfers to Ago2 by 
either concurrent or immediate Ago2-mediated cleavage of the passenger strand. ATP hydrolysis is 
required for RISC maturation to accelerate release of the cleaved passenger strands as it does for 
cleaved mRNA. Mature RISC includes only the guide strand of the siRNA, and can cleave multiple 
mRNA targets. 
The recent study indicates that the thermodynamic property of each strand in mature 
siRNA duplex determines the selection of guide strand for RISC assembly. It seems likely 
the strands with less thermodynamic stability were preferred by RISC (Khvorova et al., 
2003). 
The details of catalytic reaction remain unclear, but it is known that the PIWI domain 
of Ago protein performs the cleavage of target mRNA at the site nucleotides 10 and 11 
from 5’ end of the guide strand of siRNA. The base paired siRNA-target mRNA duplex 
may contact with the conserved triad (Asp-Asp-His) in PIWI domain of Ago to form active 
catalytic centre, allowing the mRNA cleavage. The mismatches between siRNA and 
mRNA may sabotage the formation of the catalytic centre, leading to impaired mRNA 
degradation (Figure 2.4). 
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Figure 2.9: RNAi pathway (Hannon, 2002) 
RNAi is initiated by the dimeric Dicer enzymes, which processes double stranded RNA into ~22 
nucleotide small interfering RNAs. Cleavage into precisely sized fragments is determined by the 
fact that one of the active sites in each Dicer protein is defective (indicated by asterisk), shifting the 
periodicity of cleavage from 9-11 nucleotides to ~22 nucleotides in different speices. The siRNA are 
incorporated into a multicomponent nuclease RISC which activated by unwiding of siRNAs. The 
active RISC (indicated by asterisk) then uses the unwound siRNA as a guide for substrate selection. 
Because of the remarkable potency of RNAi, an amplification step and spreading 
mechanism within the RNAi pathway were proposed. Multiple turnover effect of RISC 
induced RNA degradation mainly contributed to the amplification of the original RNAi 
signal: the cleaved mRNA targets offer new triggers to induce repeated cleavage cycle. 
Delivery of dsRNA or siRNA through plasmadesmata (cytoplasmic bridge) provides a 
possible explanation to the spreading of RNAi signal from cell to cell in a short range. The 
gene required for systemic silencing in C.elegans was identified, encoding 
transmembrane protein that may act as channel for silencing signal propagating. 
 
2.3.2 Biological roles of RNAi 
RNAi in plants is critical for the defending response to foreign genetic materials such 
as viruses or the protection against the self-propagation by transposons. It has been 
recognized as an adaptive immune system to the plant since the specific RNA-induced 
elimination of the foreign genetic materials could spread throughout entire organism from 
original encounter region. In some invertebrates such as Drosophila and C. elegans, RNAi 
is also involved in antiviral innate immunity to protect themselves from the invasion of 
pathogens. The virus-derived siRNA (viRNA) produced from viral genome induces the 
Ph.D Thesis 
 
  32 
specific silencing of virus gene through viRNA-guided effectors complexes. However, 
RNAi-mediated immunity in mammalian cells is poorly substantiated.  
The major role of RNAi appears to be in gene regulation. A group of short RNA named 
microRNAs (miRNAs) was identified as critical gene regulators in various plants and 
animals. miRNAs are produced by Dicer through processing of primary microRNA 
(pri-miRNA) transcripts from non -coding regions in the genome. The endogenously 
expressed hairpin-like miRNAs are partially complementary to either UTR or coding 
sequences of mRNA molecules from one or more genes, inducing translational repression 
or mRNA degradation through the binding of miRNA to the mRNA. The translation 
machinery could be blocked by miRNA-mRNA complex while the mRNA degradation is 
conducted through a process similar to dsRNA-induced RNAi which is triggered by the 
formation of dsRNA between miRNA and target mRNA. Gene silencing mediated by 
miRNA is believed essential for wide variety of cellular functions including developmental 
processes, proliferation, differentiation and apoptosis. miRNA in plant was shown 
important to regulate almost entire gene network during development by direct modulating 
the expression of the key transcription factors. (Jackson and Standart, 2007) 
Initially, RNAi was observed as a dsRNA-induced silencing at the post-transcriptional 
level by triggering the depletion of target mRNA without any effect on the rate of 
transcription. But accumulating evidence indicated that RNAi machinery affects gene 
functions at the level of genomic DNA through additional mechanisms including genomic 
methylation, chromatin remodeling, DNA elimination and even protein synthesis. 
RNA-induced DNA methylation (RdDM) is the first genomic modification discovered in 
RNAi world. In plants, dsRNA fragments that share sequence homology to the promoter 
region of the gene could trigger the promoter methylation, eventually leading to a 
transcriptional gene silencing (TGS) (Mette et al., 1999). Heterochromatin composed of 
degenerate retrotransposon sequences and tandem arrays of simple repeat unit has been 
long recognized as genetically inactive component in nuclei. Recently, the heterochromatic 
gene silencing and heterochromatin assembly was linked to RNAi in fission yeast (Noma et 
al., 2004). The dsRNA generated from tandem repeats and multiple copies of transposable 
elements in heterochromatin guided the histone methyltransferases to the homologous 
sites in chromatin to maintain the silenced state by modifying the heterochromatic proteins. 
The methylation of those proteins related to chromatin assembly facilitates the repression 
of transcription (Holmquist and Ashley, 2006).  
RNAi has recently been implicated in DNA elimination in which the RNAi-mediated 
heterochromatin modification go further to discard the silenced chromatin, resulting in 
restructured genome. It is also believed that the RNAi pathway crosstalks with RNA 
editing which contribute to the diversity of gene products by altering the RNA sequences 
through post-transcriptional processing machinery. A-I RNA editing in which the 
adenosine residues were converted to inosine residues is most prevalent type in higher 
eukaryotes. The RNAi pathway may share the common dsRNA substrates with the A-I 
RNA-editing machinery, indicating A-I RNA-editing may be involved in RNAi-induced gene 
silencing of the genes (Nishikura, 2006).  
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2.3.3 RNAi application 
RNAi has been applied in many organisms as a reverse genetic tool to characterize 
loss-of-function phenotypes. Increased understanding of mechanism and biological 
function of RNAi over last ten years leads to quick and significant improvements to the 
design algorithms of the artificial interfering RNA used in different systems.  
Synthetic double-stranded RNA (dsRNA) has been used as a high-throughput 
approach in plants and invertebrates to achieve selective and efficient suppression of gene 
of interest (Schmid et al., 2002). But the application is precluded in mammalians since the 
introduction of long dsRNA over 30 nucleotides provokes general gene shutdown in most 
mammalian cell types. This nonspecific suppression caused by the exogenous dsRNA has 
been attributed to the antiviral interferon response which involves dsRNA-activated protein 
kinase pathway and dsRNA-dependent RNase activation, leading to general repression of 
translation and nonspecific RNA degradation (Billy et al., 2001). This problem has been 
resolved promptly by using synthetic short hairpin RNAs (shRNA) instead of long dsRNA 
(Paddison et al., 2002; Paul et al., 2002; Sui et al., 2002). The artificial shRNA successfully 
mimics innate small interfering RNA (siRNA) produced from the cleavage of dsRNA 
initiator, inducing transient sequence-specific gene silencing in mammalians. Accordingly, 
a system using DNA constructs for shRNA expression were soon developed to achieve 
RNAi mediated gene knockdown in a stable and long-term manner in both cultured cells 
and living organisms. 
The effectiveness of siRNAs depends mainly on the sequence specificity, as single 
base pair mismatches between siRNA and target mRNA could drastically reduce the 
potency of silencing. But not all siRNAs with strict sequence specificity are effective. 
siRNAs targeting different sites on the same target mRNA show striking difference in 
silencing efficiency. This phenomenon could be explained by positional effect of the 
different accessibility of siRNAs to their target sites along the mRNA (Holen et al., 2002). 
Furthermore, gene silencing induced by siRNA could never be a gene knockout-----the 
most powerful siRNA results in reduction of target mRNA for at most 90% off.  
 
2.3.3.1 Vector-based siRNA for gene silencing 
For a long time, dsRNA and siRNA for gene silencing were synthesized chemically or 
produced by in vitro transcription. The delivery of dsRNA and siRNA into cells and 
organisms mainly rely on transfection and injection. The silencing effect could last for only 
a few days and does not appear to pass to the daughter cells. 
 
Vector-based siRNA systems have been engineered to continually express shRNA, 
which could be processed in vivo into siRNA and then cooperate into RNAi pathway for 
gene specific silencing. This system has advantages in silencing longevity, delivery 
options and economy over synthetic siRNA strategy. It also makes the conditional and 
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inducible gene silencing possible by simply introducing corresponding control elements 
into the vector system. Reportedly, the silencing effect of RNAi mediated by lentiviral 
vector could persistent for several months in mouse brain (Makinen et al., 2006). 
 
The initial designs of vector-based siRNA follow the same principle: The sequence 
encoding siRNA with 19-29 bases of homology to the target gene separated by a short 
spacer from its reverse complement part is synthesized as a double-stranded DNA 
oligonucleotide. The resulting insert was cloned into vector between a RNA polymerase III 
promoter and a 5-thymidine-in-a-row terminator (Figure 2.10). The RNA fragment 
produced by the promoters has defined start and naturally lack polyA tail. This transcript 
could fold back on itself to form a stem-loop structure with 3’-UU overhang which could be 
further processed into siRNA-like molecules, initiating the RNAi pathway. 
 
 
Figure 2.10 Schematic of vector-based siRNA expressing cassette (Paddison et 
al., 2002) 
The sequence encoding siRNA with 19-29 bases of homology to the target gene separated by a 
short spacer from its reverse complement part is synthesized and annealled as a double-stranded 
DNA oligonucleotide. The resulting insert was cloned into vector between a RNA polymerase III 
promoter and a 5-thymidine-in-a-row terminator, which served as template for the siRNA 
transcription. 
 
Promoters for siRNA transcription: Class III of RNase polymerase III (pol III) 
promoters H1 and U6 are most commonly used for siRNA transcription in vector-based 
siRNA system since they could produce small RNA transcripts lacking polyA tail that highly 
resemble to the active natural siRNA. The Pol III promoter transcribes 5s rRNA, tRNA and 
other small RNAs falling in the category of housekeeping genes required in all cell types. 
The transcription from Pol III is characterized with a well defined start and a termination 
signal consisting of a 5-thymidine stretch. Most importantly, the transcription does not rely 
on the sequences downstream of transcriptional start site, allowing the replacement of the 
original RNA gene with siRNA coding sequence. The transcriptional efficiency could be 
maintained in a high level to produce siRNA effectively both in vitro and in vivo. (Hannon 
et al., 1991) Moreover, those highly compected Pol III promoters with only a few cis-acting 
elements flanking through upstream of the start point for only 100-300 base pairs make 
them more acceptable to the space-limited viral vectors (Geiduschek and Kassavetis, 
2001) (Myslinski et al., 2001). 
 
In 2002, Sui and his colleague first demonstrated that siRNA expressed from mouse 
U6 RNA promoter in the vector can achieve robust and specific inhibition of endogenous 
target gene expression in multiple mammalian cell lines (Sui et al., 2002). Spontaneously, 
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another group developed a vector system based on human H1 RNA promoter for stable 
expressing siRNA to mediate persistent suppression of target gene in different 
mammalian cells (Brummelkamp et al., 2002).  
 
Many constructs make use of RNA polymerase II promoters to drive the expression of 
long hairpin-like RNA which can be modified by Dicer into siRNAs to achieve gene 
downregulation. But the RNA fragment longer than 30nt transcribed from Pol II promoters 
will induce interferon response in mammalian cells, resulting in unspecific effect. The RNA 
polymerase II promoters need be converted to use small DNA template to synthesize 
hairpin-like siRNA fragments with the structural features close to active siRNAs. For 
instance, the modified cytomegalovirus (CMV) promoter has been adopted to drive siRNA 
transcription in the vector-based siRNA system to diminish expression of both exogenous 
and endogenous genes in vitro and in vivo (Xia et al., 2002). 
 
Some elements could be introduced into the vector to add conditional, enhanced or 
inducible features to the gene silencing by vector-based siRNA. When an enhancer from 
CMV promoter was placed nearby to U6 promoter,  the siRNA synthesis was increased 
and consequentially the silencing of the target gene was strengthen (Xia et al., 2003). 
Cre-loxP recombination system was used to provide spatial, temporal, cell-type specific or 
tissue-specific control over U6 promoter-driven siRNA expression (Kasim et al., 2004). 
Tetracycline-responsive repressor achieves conditional regulation to siRNA transcription 
(Matsukura et al., 2003) (Matthess et al., 2005). 
 
Rational siRNA design for efficient RNAi: On the basis of the result from a systemic 
analysis of many siRNAs previously used for efficient knockdown, several groups have 
proposed a set of characteristics related to the function and efficiency of siRNA, including 
low GC content, a bias to low internal stability at the sense strand 3-terminus, lack of 
inverted repeats and sense strand base preference (Reynolds et al., 2004) (McIntyre and 
Fanning, 2006) (Taxman et al., 2006). The siRNA design incorporating those criteria 
significantly improves siRNA potency. 
 
Design and construction of siRNA begins with the selection of target sites along the 
target mRNA. Since some regions of mRNA may be either highly structured or bound by 
regulatory proteins, the siRNA target sites has to be selected 50-100 downstream from the 
start codon of mRNA. 5’ and 3’ untranslated regions (UTRs) as well as exon-exon 
boundaries within the target mRNA must be excluded from the selection. Multiple target 
sites are necessary for one gene because siRNAs targeting different sites exhibit striking 
difference in silencing potency (Holen et al., 2002). Usually 3-4 siRNA vectors targeting 
different sites should be constructed for primary screening in vitro to single out the most 
efficient ones for further application.  
 
The length of nucleotide sequence used as the stem of siRNA expression cassette 
ranges from 19 to 29nt, but the hairpin siRNAs with these various stem lengths all function 
well in gene silencing. siRNA with 2-4 Thymidine 3’ overhangs shows empirically most 
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efficient in knocking down target gene as the overhangs may play a role in protecting 
siRNA from exonuclease digestion. The addition of those unpaired overhangs to the 
siRNA duplexes does not show any obvious impairment in silencing effect and specificity 
(Miyagishi and Taira, 2002) (Harborth et al., 2003). Low G/C content (30-45%) in selected 
sequence is preferable for higher efficiency. The possible explanation is that the easier 
unwinding of hairpin structure with low G/C transcripts could facilitate processing the small 
hairpin RNA into active siRNA. U6 promoter requires an obligatory G (Guanosine) in the 
start point for initiating the transcription, whereas H1 promoter is highly permissive. 
Therefore the sequence starting with a G followed by 20 bases should be selected to 
obtain a total 21nt nucleotides sequence for constructing the U6 promoter-driven siRNA 
vector. Cluster of T residues should be strictly avoid when select the target sequence 
since the four or more T residues-stretch represents the termination signal to the Pol III 
promoters, leading to unexpected disturbance of siRNA production. To ensure the 
specificity of the RNAi, the BLAST research of the selected target sequences should be 
carried out within the corresponding genome database to exclude any homology to genes 
other than the target one.  
 
siRNA achieves gene silencing in sequence-dependent manner. A single mismatch 
between the sequence of siRNA and the target sequence would drastically sabotage the 
inhibition of gene expression. But the insertion of mutations/bulges in the sense strand of 
hairpin-type siRNA is tolerable for the effective siRNA. As many as 7 mutations from C to 
T could be introduced in the sense strand to resolve the technical problem to sequence 
through hairpin region of siRNA construct, while gene silencing activity was fully retained 
(Miyagishi et al., 2004). To increase the thermal stability for high efficiency of RNAi, siRNA 
duplexes could be chemically modified by introducing phosphoiester or phosphorthioate 
linkages into the hairpin structure (Braasch et al., 2003).  
 
Loop sequence and length are also critical to siRNA potency. siRNA transcripts 
produced in the nucleus from Pol III promoters remain inactive until they were efficiently 
processed to active form in cytoplasm. Loop motifs derived from natural microRNA were 
found helpful to improve the transportation of the siRNA transcripts from nucleus to 
cytoplasm and subsequentially promote the siRNA activation and gene knockdown 
efficiency (Chang et al., 2006) (Plasterk, 2006). 
 
Appropriate control is necessary to validate the data obtained from the experiments. 
A siRNA with same nucleotide composition as the experimental siRNA but lacks sequence 
homology to the genome could be the best negative control. 
 
Although vector-based siRNA has been proven a powerful tool to inhibit gene 
expression for better understanding of gene functions in many different cell lines and 
organisms, there are still limitations to this technology. First at all, the knockdown of the 
gene is transient even the vector-based system is relatively more resistant to RNA 
degradation than synthetic siRNA fragments. In the actively dividing cells, the silencing 
siRNA molecules transcribed from the vector were rapidly diluted to below the crucial 
Ph.D Thesis 
 
  37 
threshold which is necessary for gene inhibition. Moreover, the difficulty of plasmid 
transduction is another major obstacle for using vector-based siRNA in some cell lines 
and in living organisms. Recently, some viral vectors were developed as outstanding tool 
for easy delivery and persistent expression by integrating siRNA expressing unit into host 
genome (Michel et al., 2005). 
 
2.3.3.2 Transgene-based RNAi 
Reverse genetics is an important approach for understanding gene functions. The 
most powerful tool of reverse genetics in mammals is gene knockout technology by 
homologous recombination. But it is prohibitively complex, expensive and time-consuming 
to generate knockout animal lines with the conventional techniques. The other limitation is 
that the completely knockout of many genes may be lethal to the animal in early 
developmental stage. Recent progress has indicated that the vector-based siRNA could 
offer a time-saving and cost-effective alternative to generate transgenic lines by simply 
introducing linearized siRNA plasmid into ES cells. RNAi-induced gene knockdown effect 
can be transmitted for many generations in these transgenic animals. The lethal effect of 
gene knockout could be circumvented by generating partial and conditional transgenic 
siRNA animal lines (Xia et al., 2002; Kunath et al., 2003). 
 
Transgenic mice having reduced expression of SOD1 mutant has been generated 
with modified siRNA targeting mutated Cu/Zn superoxide dismutase (SOD1) gene. These 
transgenic animals with improved phenotype of familial ALS disease caused by the 
mutant SOD1 proteins in CNS were very helpful to elucidate the function of SOD1 gene in 
neurons in mouse CNS. A genome-wide transgenic RNAi library with 22,279 transgenic 
lines covering 88% of the predicted protein-coding genes in Drosophila genome has been 
generated for conditional inactivation of gene function in the intact organism. The library 
offers systematical analysis of the genes in Drosophila with a spatial and temporal 
resolution (Saito et al., 2005; Xia et al., 2006; Dietzl et al., 2007). 
 
2.3.3.3 Knockdown disease with RNAi 
RNAi has rapidly developed into a highly promising approach for knocking down 
disease-related gene to alleviate disease pathology. siRNAs used therapeutically in whole 
animals was first reported on 2003. siRNA duplexes targeting the gene Fas encoding the 
Fas receptor were introduced into mice via intravenous injection to reduce Fas protein 
expression in mouse hepatocytes to protect the mice from Fas-mediated apoptosis which 
cause liver failure and fibrosis in autoimmune hepatitis (Song et al., 2003). From then on, 
the siRNA-based drug development has proceeded at an astonishing speed. Generally, 
all the disease-related genes and pathogens with known sequences could be the target of 
therapeutic siRNA. The siRNA drugs offer easier and faster approaches to get through the 
test in laboratory animals and clinical trial than other conventional small molecular drugs.  
 
RNAi shows outstanding therapeutic advantages in several mouse models of human 
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neurological diseases. In the mouse model of spinocerebellar ataxia, siRNA targeting the 
mutant allele of ataxin-1 achieved a successful suppression of polyglutamine-induced 
neurodegeneration, altering disease phenotype by improving motor coordination, 
restoring cerebellar morphology and resolving ataxin-1 inclusions in Purkinje cells (Xia et 
al., 2004) (Bonini and La Spada, 2005). Those studies demonstrate the potential use of 
RNAi as powerful therapy fur dominant neurodegenerative disease. Vector-based siRNA 
also provides an especially well-suited mean for defending viral infections. Numerous 
examples illustrated that a wide range of viruses could be inhibited by RNA in vitro and in 
vivo (Dykxhoorn and Lieberman, 2006). Furthermore, the property of siRNA mimicking 
endogenous microRNA function make it valuable anticancer therapy because microRNAs 
are found very important in regulating cellular differentiation and proliferation which go 
wrong during cancer development.  
 
The therapeutic application of RNAi is now approaching clinical trials. The sirna-027 
developed by Sirna Therapeutics (Boulder, USA) as a potential drug for age-related 
macular degeneration (AMD) undergoes phase I clinical trial. AMD, resulted from macula 
damage, is the most common cause of blindness among the people over age of 55. So far 
there is no cure for AMD although laser surgery or photodynamic therapy may slow down 
the progression of the disease. Sirna-027 is a vector-based siRNA targeting to vascular 
endothelial growth factor receptor gene VEGFR-1 which stimulates the growth of new 
blood vessels, allowing to reduce the pathological angiogenesis associated with AMD. 
The chemically modified sirna-027 could be directly injected into the eyes. The phase I 
clinical trial shows a dose-dependent positive effect of this drug by stopping the 
deterioration in visual acuity. (SiRNA Therapeutics, News Release (11 July 2005), 
www.sirna.com) Moreover, PhaseI clinical trials examining siRNA-based drugs for treating 
respiratory syncytial virus (RSV) infection has finished without any report of untoward 
toxicity. Some nanoparticle-enabled siRNA-based anticancer therapies have begun 
human clinical trials. 
 
To be useful as molecular tool for studing gene functions or as drugs, siRNAs need to 
be delivered into cytoplasm of cells where they were processed to active form for 
conducting target mRNA degeneration. Most of mammalian cells can not efficiently take 
up enough siRNAs to provoke gene silencing. Direct infusion or inhalation of naked siRNA 
could be used for the drug delivery to mucosal tissue such as the respiratory tract. 
Incorperating siRNA into specialized liposome or antibody pariticle facilitated the drug 
delivery to boarder range of cells and tissues. Viral vectors are now available as most 
powerful tools to breakthrough the obstacles of siRNA drug delivery. Among them, vectors 
derived from adenoviruses and adeno-associated viruses are most frequently used for 
siRNA expression in therapeutic strategies against chronic diseases and cancer since the 
vector could incorporate siRNA transgenes into cell genome by viral integration 
(Dykxhoorn and Lieberman, 2006) (de Fougerolles et al., 2007).   
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2.4 AAV vector delivery system 
 
Adeno-associated Virus (AAV) is a small (approximately 25nm in diameter) linear 
single-stranded DNA virus that belongs to the family Parvoriridae. The first 
adeno-associated virus was isolated in early 1960’s as a contaminant of adenovirus but 
latterly identified as a replication-defective dependovirus which requires helper virus to 
facilitate its productive infection and replication. AAV infection results in the establishment 
of latent integration of viral DNA in the nucleus of the cells, while the wild type AAV can 
enter the productive cycle in the presence of helper viruses such as adenovirus (Ad), 
herpes simplex virus (HSV) or papillomavirus (HPV), leading to the replication of viral DNA 
and packaging of viral particles with pre-assembled capsids (Goncalves, 2005).  
 
AAV serotypes: To date, totally 11 AAV serotypes with over a hundred AAV variants 
have been isolated. 8 serotypes, AAV-1 to AAV-8, have been identified in primates. All of 
the known serotypes of AAV can infect multiple diverse tissue types in many species. The 
tissue and cell tropism range for each AAV serotype is determined by the surface 
topologies of virions which account for the interactions between capsid proteins and 
cellular components of the host cells. Structural and functional correlation of the AAV 
capsid has been extensively studied for better understanding of the mechanisms 
underlying their diverse tissue tropisms. The crystal structure of AAV-2 has been 
determined with X-ray crystallography, whereas the structures of AAV4 and AAV5 have 
been reconstructed using cryoelectron microscopy. The analyses on the structures of 
other AAV serotypes are currently in progress (Grimm et al., 2003). 
 
AAV2 presents its natural tropism towards murine skeletal muscles, neurons and 
hepatocytes. Among all of the AAV Serotypes, AAV-2 has been the most extensively and 
intensively examined one. The docking site for AAV-2 binding has been identified as 
heparin sulfate proteoglican (HSPG) which functions as a primary receptor while the other 
three, hepatocyte growth factor receptor (HGFR), integrin aVβ5 and fibroblast growth factor 
receptor 1(FGFR-1) act as co-receptor to enable the endocytosis for AAV uptake (Wu et 
al., 2006).  
 
Although AAV-2 is the most popular serotype in various AAV-based applications, it 
has been discovered that other serotypes can be more effective in gene delivery in certain 
circumstances respecting to their tropic binding to receptors. AAV-6 shows much strong 
infection to respiratory epithelial cells. AAV-7, AAV1 as well as AAV5 present high 
transduction efficiency to skeletal muscle cells and vascular endothelial cells, whereas 
AAV-8 shows especially powerful effect in transducing hepatocytes. AAV-3 is superior for 
the transduction of megakaryocytes. As a hybrid of AAV1 and AAV2, AAV-6 has lower 
immunogenicity than others. Utilization of the AAV vectors derived from different 
serotypes for gene delivery to different tissues not only reduces the vector load due to 
higher tissue specific transduction efficiency, but also helps to circumvent the humoral 
immune response to natural infection or prior exposure of certain AAV vectors. Based on 
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the results from the mutagenesis study of molecular structures of the parvoviruses and the 
capsid, the structural proteins of the virions could be manipulated to change tissue tropism 
to different cell types for expanding usage of AAV vectors. (Wu et al., 2006) 
 
AAV structure: AAV genome is built of either positive-sensed or negative-sensed 
single-stranded DNA of approximately 4.7 kb long flanked by two inverted terminal 
repeats (ITRs). The complete nucleotide sequence of the genome of adeno-associated 
virus 2 (AAV2) has been determined. The single-stranded genome of AAV-2 is 4,675 
nucleotides in length flanked by two ITRs of 145 nucleotides each. The ITRs are the only 
cis-acting elements needed for effective replication, encapsidation and integration of the 
AAV (Grimm, 2002).   
 
Two open reading frames (ORFs): rep (replication) and cap (capsid) were discovered 
in AAV genome, which direct the synthesis of 6 major RNA species by 3 different 
transcriptional promoters and alternative splicing signals in the mRNAs. The former ORF 
is composed of four genes encoding four nonstructural proteins Reps required for AAV life 
cycle and the latter one contains genes encoding for three structural proteins VPs which 
constitute viral capsid.  
 
In the first ORF rep, two overlapping mRNAs of different length were transcribed from 
promoter p5 and p19, respectively. Each of mRNAs contains an intron, giving rise to totally 
four various proteins translated from the two mRNAs by different splicing. The proteins are 
named according to their sizes in kilodaltons as Rep 78, Rep 68, Rep 52 and Rep40. 
Rep78 and its splicing variant Rep 68 transcribed by p5 participate in viral DNA replication, 
transcriptional control and site-specific integration through the interaction with 
Rep-binding element (RBE) and terminal resolution site (Trs) sequences located in the 
ITRs of the viral genome. Rep52 and its splicing variant Rep40 transcribed by p19 play 
essential roles in accumulation of single-stranded progeny genomes for packaging. AAV 
genome displays economic genetic organization of the virus with such overlapping 
arrangement of multiple genes (Goncalves, 2005). 
 
The transcription of capsid proteins VP1, VP2 and VP3 were all controlled by one 
promoter named p40 in the second ORF cap but the translations of three proteins have 
different initiation codons or alternative splicing sites in the single mRNA. Usually in the 
presence of helper virus adenovirus, the longer intron excision is dominant, resulting the 
2.3kb mRNA. The 2.6kb mRNA encoding VP1 protein is produced by shorter intron 
splicing. VP2 is translated from the noncanoical start codon ACG, while VP3 is translated 
from conventional start codon AUG in the shorter mRNA transcript. Apparently, VP1, VP2 
and VP3 in molecular masses of 87, 72 and 62KD differ from each other only on their 
progressively reduced N terminus. The VP1, VP2 and VP3 proteins are assembled in 
certain molecular ratio to form mature characteristic icosahedral empty AAV virion in the 
nucleus of host cells (Figure 2.11). 
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2.11: AAV Genome (by Anna Salvetti) 
AAV genome contains two open reading frames (ORFs): rep (replication) and cap (capsid), which 
directs the synthesis of 6 major RNA species by matching 3 different transcriptional promoters and 
alternative splicing signals in the mRNAs. The former ORF is composed of four genes encoding 
four nonstructural proteins Reps required for AAV life cycle and the latter one contains genes 
encoding for three structural proteins VPs which constitute viral capsid. The transcription of capsid 
proteins VP1, VP2 and VP3 were all controlled by one promoter named p40 in the second ORF cap 
but the translations of three proteins have different initiation codons or alternative splicing sites in 
the single mRNA. The 2.6kb mRNA encoding VP1 protein is produced by shorter intron splicing. 
(Figure) VP2 is translated from the noncanoical start codon ACG, while VP3 is translated from 
conventional start codon AUG in the 2.3Kb mRNA transcript. VP1, VP2 and VP3 in molecular 
masses of 87, 72 and 62KD differ from each other only on their progressively reduced N terminus. 
The VP1, VP2 and VP3 proteins are assembled in certain molecular ratio to form mature 
characteristic icosahedral empty AAV virion in the nucleus of host cells 
 
The AAV virions have an icosahedral capsid consisting of 60 copies of three structural 
proteins VP1, VP2 and VP3 at a ration of 1:1:18. VP1, VP2 and VP3 share the common 
C-terminal region called VP3 unit which comprises a conserved eight-stranded antiparallel 
beta-barrel motif. The large loops inserted between the strands of beta-barrel are 
therefore presented on the surface of protein to enable the characteristic profiles of AAV 
serotypes.  
 
Infection cycle of AAV: From infecting a cell to producing new infectious viral 
particles, the AAV infection cycle involves the following steps: First the AAV attachs to the 
host membrane by binding to specific receptors and coreceptors, followed by the 
endocytosis to enter the host cells. The AAV then goes through endosomal trafficking and 
finally translocates into the nucleus of the host where the viral genome forms the 
double-stranded DNA genome. The replication-defective AAV exists in latency form by 
integrating site-specifically into host genome DNA in the absence of helper virus. Upon the 
co-transfection with helper virus, AAV genome is rescued to enter a lytic productive phase 
where the single-stranded AAV DNA genome is synthesized and encapsidated into a 
20nm diameter capsid pre-assembled by the VP1 toVP3 proteins. The capsid assembly is 
confined in the nucleoli of the host cells. Fully assembled AAV capsids enter the 
nucleoplasm in a Rep-dependent manner where the selective DNA encapsidation is 
directed by the interaction of empty capsid and Rep proteins with the virus genome. Then, 
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the complete virions are finally released from the host cell. Although the overall pattern of 
virus assembly and encapsidation is identified, the biochemical mechanisms in these 
processes remain unknown. (Snyder and Flotte, 2002) (Seisenberger et al., 2001) (Figure 
2.12) 
 
Figure 2.12: Life cycle of AAV (by Boris Blechacz and Stephen J. Russell) 
AAV first attachs to the host membrane by binding to specific receptors and coreceptors and enters 
the host cells through endocytosis (1). The AAV then goes through endosomal trafficking and finally 
translocates into the nucleus of the host where the viral genome forms the double-stranded DNA 
genome (2). The replication-defective AAV exists in latency form by integrating site-specifically into 
host genome DNA. Upon the activation, AAV genome is rescued to enter a lytic productive phase 
where the single-stranded AAV DNA genome is synthesized and encapsidated into a 20nm 
diameter capsid pre-assembled by the VP1 toVP3 proteins (3). Fully assembled AAV capsids enter 
the nucleoplasm where the selective DNA encapsidation is directed by the interaction of empty 
capsid and Rep proteins with the virus genome. Finally, the complete virions are released from the 
host cell (4).  
 
AAV Vector: Following the establishment of the first infectious clone ofAAV-2 in 1982, 
the use of adeno-associated virus (AAV) as a gene transfer vector has been steadily 
increased over the past years mainly because it offers sustained gene expression in a 
board range of host cells both in vitro and in vivo. The extended tropism of AAV covering 
primate, canine, murine and avian cell types could be explained by the use of ubiquitous 
HSPG as primary docking sites for infection. The stable and lasting expression of the 
transgene is achieved by a stable integration of the transgene between two ITRs into host 
genome with a special predilection for a region on chromosome in both dividing cells and 
non-dividing cells. Prolonged in vivo expression of transgenes transduced by AAV-2 
vectors has been observed in liver, brain, skeletal muscle and lung of different animal 
models. 
 
The structural genes (cap) and the packaging genes (rep) are delivered in trans, 
which makes AAV an efficient recombinant vectors for gene delivery. Recombinant AAV 
vectors are derived from the wild type virus by replacing almost complete genomic 
sequence (96%) of rep and cap genes by the transgenes combined with transcriptional 
control elements. Limited cloning capacity of AAV vector can be resolved by using the 
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unique feature of ITRs to join multiple in dependent rAAV genomes by intermolecular 
recombination (Grimm, 2002; Goncalves, 2005). 
 
The minimal set of the adenoviral genes required for efficient generation of progeny 
AAV particles has been identified, allowing the new methods of helper-free recombinant 
AAV production which do not require helper virus co-infection into the cells. (Grimm et al., 
2003)The elements required for AAV packaging and Adenovirus helper functions could be 
combined on a single helper plasmid to co-transfect with rAAV plasmids for high-titer rAAV 
production in the absence of helper viruses. Since the only wild-type sequences remained 
in the recombinant viral genome are the AAV ITRs, the immunogenicity and direct cellular 
toxicity caused by viral proteins and contaminating helper viruses can be completely 
avoided. Direct administration of rAAV vectors results in persistent transduction of cells 
with mild humoral immune response which could be overcome by transient immune 
suppression (Zolotukhin, 2005).  
 
AAV vectors for gene therapy: To be clinically applicable, the viral vectors should 
be replication-defective, non-immunogenic, non-toxic but still able to deliver transgenes 
efficiently into nucleus of the host cells. The non-pathogenic character, lack of viral genes, 
lack of cellular toxicity, the ability to confer long-term gene expression, ability to generate 
high titer vector preparation and board range of tissue tropism makes AAV a very 
appealing candidate for creating viral vector for safe gene therapy in human. Despite 
approximately 80% of human population is seropositive for AAV-2, so far no human 
disease has been related to AAV. The cloning and manipulation of rAAV vector could be 
carried out in ordinary laboratory in Biological Safety Class I level. Additionally, AAV is 
particular suitable to clinical use due to its apparent limited capacity to provoke immune 
response in human, thus reducing the risk of any immune-associated pathology. Since the 
transgene flanked by the two ITRs could be integrated into host genome with a special 
predilection for a region on chromosome 19 in human to achieve stable and lasting 
expression, multiple administrations are not necessary. Besides, ability of efficiently 
transduce highly differentiated postmitotic cells such as neurons allows recombinant AAV 
vector a valuable alternative to other gene delivery systems in CNS and PNS which have 
very low accessibility for other delivery methods (Ruitenberg et al., 2002) (Kaspar et al., 
2002) (Paterna and Bueler, 2002). 
 
Recombinant AAV-2 vectors have been examined in preclinical studies for a variety of 
diseases such as hemophilia and Duchenne muscular dystrophy. Over 10 different AAV-2 
based vectors have been administered in patients in clinical trials as therapeutic drugs. 
The AAV-mediated treatment of hemophilia B has resulted in very promising therapy in the 
clinical trial (Tenenbaum et al., 2004). 
 
However the AAV-2 vectors show rather limited efficiency in infecting a number of 
clinically relevant cells of therapeutic interest, such as liver and muscle cells. Another 
inherent drawback hampering the gene transfer by AAV2 vectors is that the majority of 
human population has been prevalently exposed to AAV2, thus carrying the neutralizing 
Ph.D Thesis 
 
  44 
antibodies against vectors derived from AAV-2. Those problems could be resolved either 
by using other naturally occurring serotypes of AAV such as AAV1, 4, 5 and 6 or by 
changing tissue/cellular specificity through modification of vector genomes and capsid 
proteins. The mosaic virion is generated by using the helper constructs which encodes 
mixing capsid subunits from different serotypes. The mosaic rAAV1/2 generated from 
helper plasmid expressing capsid proteins from AAV1 and AAV2 has more comprehensive 
infection panel which combines characteristic tropisms of the two serotypes. Chimeric 
rAAV is such kind of hybrid vectors containing capsid proteins that has been engineered 
by exchanging domain or amino acid between different serotypes. Specific capsid 
domains such as surface loops which are vital for determining tissue tropism could be 
replaced from one serotype to another, resulting in gain or loss of certain tissue specificity. 
Those pseudotyped vectors have shown improved potency and broadened tropism of 
AAV vector (Thomas et al., 2003). 
 
To further improve the recombinant AAV delivery system, different cellular promoters 
were used to drive the transgene in the vector for different expressing pattern. For 
instance, PDGF promoter used in AAV vectors offering higher neuron specificity than CMV 
promoter was used in mouse brain. Conditional and inducible features of the transgenes 
could also be realized by corresponding transcriptional elements (Kugler et al., 2001) 
(Ehrengruber et al., 2001). 
 
Gene silencing through small interfering RNAs (siRNAs) is rapidly becoming a 
powerful tool for genetic analysis of mammalian cells. Recently, recombinant AAV vectors 
have achieved a successful siRNA delivery in mammalian cells, which overcomes the 
problem of poor transfection efficiency of the plasmid-based siRNA systems. High 
specificity and efficiency of the rAAV-siRNA delivery system make it a promising tool for 
gene therapy in human by knocking down disease-related genes (Tomar et al., 2003). 
 
In an attempt to search for potent AAV vectors with enhanced performance profiles, 
molecular techniques were used for the identification and isolation of endogenous AAVs 
from a variety of primate tissues. A family of novel primate AAVs consisting of 110 
non-redundant species of proviral sequences was discovered and turned to be prevalent 
in 18-19% of the tissues evaluated. Initial evaluation of vectors based on these novel 
AAVs for tissue tropism and gene transfer potency in mouse models led to the discovery 
of vectors with improved gene transfer efficiency to different target tissues. Gene 
therapies with novel AAV vectors have achieved long term phenotypic corrections in 
several animal models. Vectors based on new primate AAVs could become the next 
generation of efficient gene transfer vehicles for various gene therapy applications. 
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III. Materials and Methods 
 
3.1 Construction of parent vectors 
 
3.1.1 pBlueU6 
The promoter of the mouse U6 RNA gene (GenBank access number: X06980, 
-315~0) was isolated by PCR using a genomic DNA template from BL6 mouse with the 
sense primer 5’-GCGGATCC (BamH I)GACGCCATCTCTA-3’ and the antisense primer 
5’-GCTCTAGA(Xba I)GCGTTAAC(Hpa I)AAGGCTTTT- CTCCAAGG-3’. The resulting 
PCR product digested with RE BamH I and Xba I was cloned into a pBluescript II SK(+) 
vector  (Stratagene) to form pBlueU6 (Figure 3.1). The Hpa I and Xba I sites introduced 
by the antisense primer allow the insertion of the siRNA sequence into the transcriptional 
frame under the mouse U6 RNA promoter. 
 
If not specified, the restriction endonucleases (REs) used in this project are products 
from New England Biolabs (NEB). The rapid DNA ligation kit (Roche applied sciences) 
was used for fast and efficient cloning. A PCR purification kit, Gel extraction kit, Plasmid 
Maxiprep and Miniprep kit allowed easy purification of the PCR products, DNA fragments 
and ultrapure plasmid DNA. 
 
3.1.2 pBlue-hU6 
The promoter of the human U6 RNA gene (GenBank access number: X07425, 
-250~0) was isolated by PCR using a genomic DNA template from a human skin sample 
(kindly provided by Dr. Sabine Wenner’s Lab, Cell. Biol. Inst., ETH) with the sense primer 
5’-GCCTCGAG (Xho I) AGAGGGCCTATT- TCCCATGA-3’ and antisense primer 
5’-CCCAAGCTT (Hind III)AAAAAGGTGTTTCGT- CCTTTCCAC-3’. The resulting PCR 
fragment digested with Xho I and Hind III was cloned into a pBluescript II SK(+) vector to 
obtain pBlue-hU6. 
 
3.1.3 pBlue-hH1 
The promoter of the human H1 RNA gene (GenBank access number: S68670, -97~0) 
was isolated by PCR using genomic DNA template from a human skin sample with the 
sense primer 5’-GCCTCGAG(Xho I)ATTTGCATGTCG- CTATGTGT-3’ and antisense 
primer 5’-CCCAAGCTT(Hind III)AAAAAG- GGGAAAGAGTGGTCTCATA-3’. The resulting 
PCR fragment digested with Xho I and Hind III was cloned into a pBluescript II SK (+) 
vector to create pBlue-hH1. 
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Figure 3.1: Construction of the vector containing the mouse U6 RNA promoter 
The promoter of the mouse U6 RNA gene was isolated by PCR using a genomic DNA template from 
BL6 mouse with primers. The resulting PCR product digested with RE BamH I and Xba I was 
cloned into a pBluescript II SK (+) vector. The Hpa I and Xba I sites introduced by the antisense 
primer allow the insertion of the siRNA sequence into the transcriptional frame under the mouse U6 
RNA promoter. 
 
 
3.1.4 Construction of an AAV vector containing an EGFP marker 
 
The psubAAV2-CBA-WPRE vector (kindly provided by Dr. Hansruedi Bueler’s lab, 
Inst. Mol. Biol, Uni. of Zurich) was digested with Kpn I and Hpa I to remove the 
CBA-WPRE promoter-enhancer sequence. The CMV promoter conducted EGFP 
expression cassette was obtained by digesting pEGFP-N1 (ClonTech.) with Afl II and Afl 
III (1630bp fragment). The vector and fragment blunted with Klenow (Roche) were ligated 
together to form psubAAV2-CMV-EGFPN1. The resulting plasmids were identified and 
characterized by RE analysis and transfected into HEK293T cells to detect green 
fluorescence.  
 
3.1.5 Construction of an AAV vector expressing calsyntenin-1 
 
The 3200bp fragment resulting from the digestion of pcDNA3.1-mmCst1 (kindly 
provided by Dr. Peter Sonderegger’s Lab, Biochem. Inst. Uni. of Zurich) with Sac I was 
blunted with Klenow and then cloned into a psubAAV-CMV-EGFPN1 vector linearized and 
blunted at Nhe I and Hpa I sites to form the psubAAV2-CMV-Cst1 construct. 
 
pBlueScript II SK (+)
2961 bp
¦Â-galactosidase
Ampicillin
P lac
f1 (+) ori
pUC origin
ApaI  664
BamHI  720
Cla I  685
EcoRI  702
EcoRV  698
HindIII  690
KpnI  658
Not I  739
Pst I  712
Sac I  760
Sac II  751
Sal I  675
Sca I  2527
Sma I  716
Xba I  732
XhoI  669
Xma I  714
NaeI  331
pBlueU6
3269 bp
Ampicillin
U6 promoter
P lac
f1 (+) ori
pUC origin
Apa I  664
BamHI  720
Cla I  685
Eco RI  702
Eco RV  698
HindIII  690
Hpa I  1034
Kpn I  658
Not I  1047
Pst I  712
Sac I  1068
Sac II  1059
Sal I  675
Sca I  2835
Sma I  716
Xba I  1040
Xho I  669
Xma I  714
 
Mouse U6 RNA promoter 
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3.1.6 Construction of an AAV vector containing the EGFP-2A fusion frame 
 
Using pEGFP-N1 vector as template, the EGFP sequence was amplified by a 
two-round nest-PCR with the forward primer 5’-CTAGCTAGC(Nhe 
I)ATGGTGAGCAAGGGCGAGGAGC-3’ and two reverse primers containing the 2A 
sequence derived from the foot and mouth disease virus (FMDV) gene 
5’-TCCCGCAAGCTTAAGAAGGTCAAAATTCTTGTACAGCTCGTCCATGCCGAG-3’, 
5’-GGTGTACA(BsrG I)GGGCCC(Apa I)AGGGTTGGACTCGAC- 
GTCTCCCGCAGGCTTAGGAAGG-3’. 
 
The resulting PCR product containing the EGFP-2A fusion gene cassette was cloned 
into a psubAAV2-CMV-EGFPN1 vector between the Nhe I and BsrG I sites to form the 
psubAAV2-CMV-EGFP2A construct. The Apa I and BsrG I sites were introduced with a 
second antisense primer to facilitate the cloning of coding sequences to express 2A linked 
EGFP fusion protein in the genes of interest. Upon translation, the 16aa FMDA 2A peptide 
(NFDLLKLAGDVESNPG) mediates self-cleavage on its own C-terminus to give rise to an 
EGFP marker fused with a 2A tag and the intacting target protein (Figure 3.2). 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.2: Schematic illustration of the construction of the 2A linked EGFP 
fusion protein 
A: Nest PCR amplification to construct the EGFP-2A fusion frame: Using pEGFP-N1 vector as 
template, the EGFP sequence (green) was amplified by a two-round nest-PCR with the primers 
which contains 2A sequence (red) in the antisense primers. 
B: The self-cleavage of the fusion protein by the FMDV 2A peptide: Upon translation, the FMDA 2A 
peptide mediates self-cleavage on its own C-terminus to give rise to an EGFP marker fused with a 
2A tag and the intacting target protein (blue). 
 
EGFP-2A Protein of interest 
ITR pCMV 2AEGFP
A 
B 
ITR 
Protein of interest
Primers 
EGFP-2A fusion frame 
EGFP sequence 
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3.2 Design and Cloning strategies for constructing siRNA expression 
vectors 
 
3.2.1 Hairpin-type siRNA 
The general strategy for constructing hairpin-type siRNA vector involves the design, 
synthesis, annealing of two complementary oligonucleotides into a double-stranded DNA 
insert, and subsequent cloning of the insert into a siRNA expression vector.  
 
The insert is designed such that it specifies a 19nt sequence derived from the open 
reading frame of the target gene, separated by a 9nt spacer from its 19nt reverse 
complementary sequence plus a termination signal consisting of five thymidines in a row. 
The insert provides a template for the RNA polymerase III RNA promoter to produce 
hairpin RNA transcripts. For each target site, one pair of complementary oligonucleotides 
is chemically synthesized and annealed to form a double-stranded DNA insert with 
overhangs that could be cloned into the pBlueU6 vector linearized with Hpa I and Xba I 
(Figure3.3). 
 
 
 
 
 
 
 
Figure 3.3: Design and cloning of the oligonucleotides 
Two complementary oligonucleotides are chemically synthesized and annealed to form a 
double-stranded DNA insert with overhangs. The resuting insert is cloned into the pBlueU6 vector 
linearized with Hpa I and Xba I. 
 
Annealing oligos with a PCR apparatus: The oligos (SIGMA 0.05 μmole scale, 
purified by HPLC) were dissolved in ddH2O to give a final concentration of 3μg/μl. The two 
oligos were mixed in equal molar ratio in annealing buffer (100 mM potassium acetate, 30 
mM Hepes-KOH pH 7.4, 2 mM Mg-acetate) and incubated at 95°C for 5 minutes, 70°Cfor 
10 minutes, then slowly cooled down to 4°C. The resulting products can be stored long 
term at -20°C. 
 
Phosphorylation of annealed insert: The inserts were treated with polynucleotide 
kinase (T4 PNK kit, Roche) for 30 minutes at 37°C then incubated for 10 minutes at 70°C 
in a heating block to deactivate PNK. Ligation (Roche rapid ligation kit): PNK treated oligo 
inserts were mixed with pBlueU6 vector linearized with Hpa I and Xba I in a molar ratio 2:1 
in ligation buffer, incubated at RT for 30 minutes. Small amount of the resulting ligation 
mixture was used to transform bacterial competent cells (E.coli. XL-Blue, prepared 
according to the Super-competent Cell Protocol provided by Dr. Jingxuan Yang, ETH. Cell 
Biology Institute). The bacterial colonies were screened and identified with RE analysis 
and sequencing for desired clones (Figure 3.4). 
 
Oligo 1 
Mouse U6 RNA promoter 
T(N19)TTCAAGAGA(N19) TTTTT 
Oligo 2 Hpa I site Xba I site
A(N19)AAGTTCTCT(N19) AAAAAGATC 
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pBlueU63269 bp
Ampicillin
U6 promoter
P lac
f1 (+) ori
pUC origin
ApaI  664
BamHI  720
Cla I  685
EcoRI  702
EcoRV  698
HindIII  690
Hpa I  1034
KpnI  658
Not I  1047
Pst I  712
Sac I  1068
Sac II  1059
Sal I  675
Sca I  2835
Sma I  716
XbaI  1040
XhoI  669
Xma I  714
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.4: Construction of hairpin-type nonsense siRNA expression 
vector with pBlue-mU6 
PNK treated nonsense siRNA inserts were cloned into pBlueU6 vector linearized with Hpa I and 
Xba I to form the hairpin-type nonsense siRNA expression vector. 
 
 
3.2.2 Tandem-type siRNA 
The tandem-type siRNA expression vector employs two independent mouse U6 
promoter cassettes to produce sense and antisense RNA transcripts of the target 
sequence simultaneously. After the transcription of the individual single-stranded RNA, 
these two complementary transcripts could anneal for further processing to form an active 
siRNA duplex. 
 
Using the mouse U6 promoter sequence serving as template, two independent PCR 
reactions were conducted with two reverse primers containing sense and antisense siRNA 
sequence respectively. The resulting PCR products containing the mouse U6 promoter 
conducted sense and antisense siRNA expressing cassettes were digested with 
corresponding restriction enzymes and then cloned into pBluescript.II SK(+) (Figure 3.5). 
 
pBlueU6-Nonsense
3317 bp
Ampicillin
U6 promoter
P lac
f1 (+) ori
pUC origin
Nonsnese
Apa I  664
BamHI  720
Cla I  685
Eco RI  702
Eco RV  698
HindIII  690
Kpn I  658
Not I  1095
Pst I  712
Sac I  1116
Sac II  1107
Sal I  675
Sca I  2883
Xba I  1088
Xho I  669
 
TTTTT 
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Figure 3.5: Construction of a tandem type siRNA expression vector 
Using the mouse U6 promoter sequence serve as template, two independent PCR reactions were 
conducted with two sets of reverse primers containing sense and antisense siRNA sequence 
respectively. The resulting PCR products containing the mouse U6 promoter conducted sense and 
antisense siRNA expressing cassettes were digested with corresponding restriction enzymes and 
then cloned into pBluescript.II SK(+). The resulting vector produces two individual complementary 
transcripts which could anneal to each other to form the active siRNA duplexes. 
 
3.2.3 PCR approach for constructing hairpin type siRNA expression vector  
Using the human U6 RNA gene and its 3’ flanking sequence on a pBlue-hU6 vector 
as templates, two PCR fragment was amplified with two pairs of primers that contain 
sense and antisense siRNA sequences within their reverse primer and forward primer, 
respectively. 
 
The resulting PCR products were digested with corresponding enzymes and cloned 
into pBluescript.II SK (+) independently. After sequencing identification, the fragment 
containing the antisense siRNA sequence from one plasmid was cloned into another 
plasmid containing the sense siRNA sequence to form a human U6 promoter-conducted 
hairpin type siRNA expressing cassette.   
antisense
TTTTT 
TTTTT 
TTTTT TTTTT 
Primer pair 1 
Primer pair 2 
Template: mouse U6 RNA promoter 
Mouse U6 RNA promoter Mouse U6 RNA promoterSense antisense 
Sense
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Figure 3.6: PCR approach for constructing a hairpin type siRNA expression 
vector. 
Using the human U6 RNA gene and its 3’ flanking sequence on a pBlue-hU6 vector as templates, 
two PCR fragment was amplified with two pairs of primers that contain sense and antisense siRNA 
sequences within their reverse primer and forward primer, respectively. The resulting PCR products 
digested with corresponding enzymes were cloned into pBluescript.II SK (+) independently. After 
sequencing identification, the fragment containing the antisense siRNA sequence from one plasmid 
was cloned into another plasmid containing the sense siRNA sequence to form a human U6 
promoter-conducted hairpin type siRNA expressing cassette.  
 
3.3  Cell culture 
 
3.3.1 The NG108-15 cell line  
The NG108-15 cell line is a hybrid dividing culture resulting from the fusion of mouse 
neuroblastoma and glioma, which still expresses many neuronal properties. NG108-15 
cells were cultured in DMEM medium (Gibco: 21969-035. Invitrogen) supplemented with 
10% FCS, 4 mM L-glutamine, HAT (100 μM hypoxantine, 1 μM aminopterin, 16 μM 
thymidine), 100 U/ml penicillin-streptomycin (Gibco 15140-122) in the incubator at 37°C 
with 5% CO2. Cells were seeded at 1:5 onto fresh culture plates when reaching 
confluence. Cells with more than 5 passages were seeded onto a 12-well-plate (Nunclon, 
Nunc) at a concentration of 1 X 105 cells/well 24 hours before experiments, 
 
3.3.2 The HEK 293T cell line  
The cells were cultured in DMEM medium (Gibco: 21969-035 Invitrogen) 
supplemented with 10% FCS, 5 mM L-glutamine, 0.1 mM sodium-pyruvate, 100 U/ml 
penicillin-streptomycin in the incubator at 37°C with 5% CO2. Cells were diluted at 1:10 in 
fresh culture when reaching confluence. Cells with more than 5 passages were used for 
transfection. 
 
TTTTT 
TTTTT 
TTTTT 
Primer pair 1 
Template 
Fragment 1 
Primer pair 2 
Fragment 2 
Human U6 RNA promoter
Human U6 RNA promoter
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3.3.3 Primary hippocampal neuronal cultur:  
(Modified from P. Sonderegger’s Lab protocol developed by Renato Frischknecht and 
Anna Fejtova)  
A pregnant mouse was killed by cervical dislocation and the E18 embryos were taken 
out from the uterus. The heads of embryos were collected in Petri dishes containing 
ice-cold HBSS+ (Gibco:14025-050 Invitrogen). After removing the skin, skull and 
meninges with forceps, the hippocampi were dissected out from the brain with fine 
scissors and washed twice with HBSS- (Gibco: 14175-053 Invitrogen). To disassociate the 
cells, the hippocampi were incubated 5 minutes at 37°C n 0.25% trypsin (Gibco 
25090-028 Invitrogen). Pouring off the solution carefully, the tissue clump was washed 
with plating medium (DMEM Gibco: 31053-028 supplemented by 10% FCS, 1 mM sodium 
pyruvate, 5 mM glutamine, 0.5 mg/ml albumax). The tissue was triturated in plating 
medium carefully by pipetting several times. Cells were counted with a microscope 
counting chamber and diluted to the desired concentration with plating medium. 
 
Culturing the primary neuronal cells on cover slips: The 20mm round glass coverslips 
(Deckgläser, Germany) were incubated with 99% ethanol for 10 minutes at RT, followed 
by washing three times with sterile ddH2O. After the overnight incubation in coating buffer 
(0.5 mg/ml poly-L-lysine, 150 mM sodium borate, pH 8.4, sterilized by filtering through a 
0.45 um filter) at 37°C, coated coverslips were washed three times with sterile water, and 
dried in the laminar flow hood. 
 
100 µl of the cell suspension were plated on coated coverslips, incubated for 1 hour 
in a 37°C incubator with a 5% CO2 supply, then transferred onto coverslips to a 
12-well-plate containing 1 ml culturing medium of DMEM (Gibco:31053-029) 
supplemented with 10% FCS, 1 mM sodium pyruvate, 5 mM glutamine, 0.5 mg/ml 
albumax, 2% B27 (Gibco:17504-44). The cytosine arabinoside (AraC, Calbiochem: 
251010) was added to a final concentration of 15 μM to prevent the outgrowth of glial cells. 
The cells were fed by adding 100µl of culturing medium every 10 days.  
 
To grow the cells on plastic culture plates, the same protocol was used except that 
the coating concentration of poly-L-lysine was 20μg/ml. For low density culture, a glial 
feeder layer was pre-established on the poly-L-lysine coated culture dishes to support the 
growth and differentiation of neurons. 
 
The glial feeder cells were prepared from postnatal 1 day mouse: Cortexes were 
collected in HBSS and trypsinized with 0.25% trypsin. Tissue was triturated and diluted in 
neuron plating medium (as described above) to the desired concentration. Cells were 
cultured in Petri dishes until they reached confluence. Glial feeder cells were resuspended 
by trypsinization and plated on the culture plates (Nunc) at a density of 0.5 x 105 cells/cm2. 
The cover slips with primary neuronal culture were placed on the plates upside down, so 
the neuron side faced the bottom of the dishes. 
 
The Paraplast Tissue Embedding Medium (Sherwood medical:8889-501007) was 
Ph.D Thesis 
 
  53 
heated to 150°C until it was in the melted state, then three drops of the melted embedding 
medium were deposited on the plates with a glass pipette providing support for the cover 
slips when it became solid. 
 
 
3.4 Transient transfection of NG108-15 and HEK 293T cells using the 
lipofectamine 2000 reagent (Invitrogen) 
 
For adherent HEK 293T and NG108-15 cells, cells were seeded 24 hours before 
transfection at a concentration of 1 x 105 cells /ml. The plasmids were diluted with 
OptiMEM medium I (Gibco: 31985-047, Invitrogen) to 10 µg/ml in Eppendorf tubes. The 
lipofectamine reagent was diluted to 10% (V/V) with OptiMEM medium. The plasmid and 
lipofectamine solutions were mixed together and incubated 30 minutes at RT to form the 
plasmid-lipofectamine complex. The mixture was added dropwise to cell culture dishes. 
Changing the medium was not necessary. 24 hours later, the transfected cells could be 
used for further experiments. 
 
3.5  Stoppini type hippocampal slice culture 
(Modified from the Cold Spring Harbor protocol developed by Leah Fuller and Michael 
E. Dailey) 
 
Post-natal 6 days C57BL/6 mice were killed by quick decapitation with scissors. The 
heads were dissected with fine tip surgical scissors to expose the brain. Cerebrums were 
collected in Petri dishes filled with ice-cold dissection solution GBSS++ (Gibco Hank’s 
balanced salt solution, supplemented with 6mg/ml glucose), then the hippocampus were 
excised from the brain with blunt spatula and fine forceps.  
 
The hippocampus was cut into transverse sections at an interval of 300 µm with a 
tissue chopper. The slices were separated and plated on Millicell-CM Organotypic Cell 
Culture Inserts (Millipore: 0.4 µm) in a 6-well-plate filled with 1 ml culture medium (48.5% 
BME, 25% HBSS, 25% heat-inactivated horse serum supplemented with 4 mM 
L-glutamine and 6 mg/ml glucose. pH: 7.2-7.4.) The slices on the membrane were 
maintained in the interface between the atmosphere and medium in the incubator at 35°C, 
5% CO2, 95% humidity. The medium was changed every 3 days.  
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3.6 Introducing plasmid DNA into hippocampal slice cultures via 
electroporation 
 
 
Figure 3.7 Electroporation in organotypic cultures 
A: Self-made electroporation device 
B: Schematic illustration of the electroporation setup: The slice cultures are placed between two 
parallel electrodes. The chamber is filled with DNA solution and the electric field is applied to 
introduce DNA into slice culture. 
C: Current density measurement and distribution between paired electrodes 
  
The experiment was conducted under sterile conditions in a laminar flow hood. The 
Millicell membrane insert (Millipore: 0.4 µm hydrophilic PTFE) carrying the hippocampal 
slices was transferred into the Ф3.5 mm sterile Petri dishes filled with 2 ml pulsing buffer 
(Gibco HBSS supplemented with 20 mM HEPES, pH 7.2). The Petri dishes were mounted 
in the electroporation device such that the target slice was positioned between the two 
parallel electrodes. A 2 mm-high plastic ring (Ф4.0 mm inner diameter, cut from 
polyethylene tube with a razor blade, flame polished) was placed so as to enclose part of 
the slice culture. The chamber formed by the ring was filled with a 1.0 µg/ul DNA solution 
diluted with pulsing buffer. The cathode was attached to the membrane from the bottom of 
the membrane insert and the anode was placed on top of the plastic ring to make contact 
with the DNA solution.  
 
The electric field was generated by an ECM830 electroporator (BTX). The 
electroporation parameters were optimized to a voltage of 125 V, a pulse number of 6, a 
pulse length of 50 ms, and a pulse interval of 1s to minimize damage to the slices. The 
insert was washed with medium to remove the debris and pulsing buffer before it was 
returned to the culture plate for further culturing (Figure 3.7). 
 
 
Membrane insert 
Plastic ring 
Slice culture 
Petri dishes 
DNA solution 
Pulsing buffer 
Anode Cathode 
C 
A B 
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3.7 Counting EGFP positive cells with Flow Cytometry 
 
24 hours after the transfection, the NG108-15 cells were trypsinized and collected by 
centrifugation, then resuspended with PBS containing 0.2 % Triton X-100 at RT for 20-30 
minutes. After washing with PBS, cells were collected and equilibrated with 0.5 ml flow 
cytometry buffer (PBS supplemented with 2% FCS, 1 mM MgCl2 and 1 mM CaCl2). 
  
A Beckmann-Coulter EPICS XL bench-top instrument and System II Data Acquisition 
& Display software were used to count the green fluorescent cells. The emission was 
measured at FL3 (long pass filter 670 nm) to determine the region for live cells. Detection 
was set at the FL1 channel (525 nm band pass filter) to measure the emission of green 
fluorescence from EGFP positive cells. The data on scatter parameters and histograms 
were recorded in log mode until 10,000 events were evaluated. The peak value obtained 
from the histograms represents the fluorescent intensity of the sample.  
 
  
3.8 AAV preparation and purification 
 
3.8.1 Packaging of AAV particles:  
(Modified after the Grimm protocol, Human Gene Therapy, 9.2745-2760). 
In general, to produce adenovirus-free rAAV particles, 293T cells are transiently 
co-transfected with rAAV vector plasmid and helper plasmid pDG, which contains 
adenovirus helper and all elements involving AAV packaging function. 
 
HEK 293T cells were seeded on 20 culture plates (Ф15 cm, Cellstar: 639160) with 1.5 
x107 cells per plate. The cell density reached about 70% confluence after 24 hours. Cells 
were transferred to fresh medium without antibiotics and incubates for 2~3 hours. The 
mixture of rAAV plasmid and helper plasmid pDG was prepared in an equal molar ratio 
according to the formula: Y µg rAAV plasmid = (1000 µg pDG helper X length in Kb of 
rAAV plasmid.)/21.8kb 
 
The plasmids were mixed with 3.0 ml 2.5 M CaCl2 buffer (2.5 M CaCl2 in H2O, stored 
at -20°C in 20 ml aliquots), then diluted with sterile ddH2O to a final volume of 25 ml.  
10 polystyrene snap cap tubes (Falcon, 12ml) were prepared with 2.5 ml HeBs buffer 
(NaCl, HEPES, Na2HPO4 in H2O, pH adjusted to 7.12 with NaOH, stored at -20°Cin 50 ml 
aliquots.) in each tube. 2.5 ml of DNA/CaCl2 mixture was added dropwise into each tube, 
mixed by gently tapping and incubated for 5 minutes at room temperature.  
 
2.5 ml of the mixture was divided dropwise into each cell culture plate and mixed 
gently. After incubating overnight at 37°C, 5% CO2, cells were cultured in 25 ml fresh 
medium containing antibiotics (100U/ml penicillin-streptomycin). 48~52 hours after the 
transfection, cells were collected into sterile 50 ml Falcon tubes with plastic cell spatula 
and centrifuged at 1200 rpm for 5 minutes at 4°C. 
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To prepare the cell lysate, the cell pellet was resuspended in resuspension buffer 
(0.15 M NaCl, 50 mM Tris-HCl, pH: 8.5) to a final volume 15 ml. The cells were frozen and 
thawed two times by transferring tubes between liquid nitrogen and a 37°C water bath. 
The tubes were vortexed at full speed for 1 minute after each thawing to dissolve cell 
clumps. the mixture wa passed through a 21 G needle using a 10 ml syringe to further 
remove cell clumps. 
 
3.8.2:  Purification with iodixanol gradients  
(Modifed after the Grimm protocol. Human Gene Therapy, 9.2745-2760). 
Benzonase (Sigma-Aldrich) was added into the cell lysate to a final concentration of 
50 U/ml and the mixture was incubated for 30 minutes at 37°C.  
The clear lysate was obtained by centrifugation at 7000 rpm for 20 minutes at 15°C in a 
SS-34 rotor (Beckman) to remove cell debris. The supernatant was transferred to a 50 ml 
Falcon tube and filled to a final volume of 15 ml with the resuspension buffer (as describe 
above).  
 
The 25 x 89 Beckman Ultraclear quick-seal tubes were loaded with lysate and 
iodixanol gradient medium with a long needle fitted to a syringe or peristaltic pump. The 
gradient (from top to bottom) consisted of 15 ml cleared lysate; 9 ml 15% iodixanol in a 
PBS-MK-high salt buffer; 6 ml 25% iodixanol in PBS-MK buffer supplemented with 15 µl 
0.5% Phenored (red); 5 ml 40% iodixanol in PBS-MK buffer; 5 ml 57% iodixanol in PBS 
Supplemented with 12.5 µl 0.5% Phenored (red). 
 
The tubes were balanced with fluid until the difference between tubes was less than 
0.08 g. The tubes were sealed with tube sealer (Beckman 357442). The tubes were 
centrifuged in a Type 70i Beckman fixed-angle rotor at 55,000 rpm for 90 minutes at 18°C. 
 
Tubes were wiped with 70% ethanol followed by puncturing from the side with a 20 G 
needle connected to a 5 ml syringe at a level 1-2 mm above the boundary between 40% 
and 57% iodixanol gradient zones. Then, a 23 G needle was used to puncture the top of 
the tube to allow air to enter the tube. The clear 40% iodixanol fraction containing rAAV 
particles was slowly aspirated into the syringe. 
 
The rAAV solution was concentrated to 1 ml with a Biomax-100K NMWL filter device 
(Millipore UFC910024) by centrifugation. After washing three times with PBS, the 
concentrated rAAV solution aliquots were stored at -80°C 
 
The stock solution used in the gradient:  
2 x PBS-MK-high salt buffer: 2 M NaCl, 20 mM Na2PO4, 20 mM NaH2PO4, 2 mM MgCl2, 
5 mM KCl 
10 x PBS-MK buffer: 1.37 M NaCl, 100 mM Na2PO4, 100 mM NaH2PO4, 10 mM MgCl2, 
25 mM KCl 
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3.8.3 Purification with heparin affinity chromatography  
(Modifed after the SSCP method from the Wilson Lab, Human Gene Therapy 
12:71-76.2001) 
The cell lysate (15 ml) was incubated with 0.1 mg DNase I and RNase A (Roche) 30 
mintues at 37°C, cleared by centrifugation at 3000 rpm for 15 minutes at 4°C. Deoxycholic 
acid was added to the lysate to a final concentration of 0.5% and incubated at 37°C for 30 
minutes. Then the lysate was passed through 5µm and 0.45µm pore-size filters 
sequentially to remove debris.  
8 ml of the heparin agarose suspension was loaded into the 2.5-cm-diameter glass 
column equipped with a Luer Lock. The matrix was equilibrated with 25 ml PBS, pH 7.4. 
 
The cleared lysate was passed through the heparin agarose column at a flow speed 
of 1 drop/second. The matrix was washed with 15 ml of low-salt PBS (PBS supplemented 
with 0.1 M NaCl, pH 7.4) twice. The AAV particles were eluted with 15 ml high-salt PBS 
(PBS supplemented with 0.4 M NaCl. pH 7.4) and concentrated to the desired volume 
with a Biomax-100K NMWL filter device (Millipore UFC910024) by centrifugation. After 
washing three times with PBS, the concentrated rAAV solution aliquots were stored at 
-80°C 
 
Titers of the rAAV were determined by optical density measurement (Molecular 
Therapy: vol.7, No.1 Method). The UV absorbance at 260 nm and 280 nm of the 
denatured rAAV samples were measured with a spectrometer (Ultrospec 2000, 
Pharmacia Biotech). The molar extinction coefficients of the combined capsid proteins 
were determined empirically by amino acid analysis; the absorbance at 260 nm and the 
260nm/280nm ratio were used to calculate the concentration of the rAAV vector genome 
according to the formula: Vector genome/ml = 4.47 x 1019 (A260-0.59A280)/MWDNA 
 
3.9 PAGE and immunoblot 
 
A reducing SDS-PAGE system with 7.5% or 10% polyacrylamide gel was used to 
evaluate protein samples from cell extracts.  
 
Protein sample preparation: Cell extracts were prepared by resuspending and 
incubating cells in lysis buffer (50 mM Tris, 150 mM NaCl, 2 mM EDTA, 1% Triton-100) for 
30 minutes at RT.  Protein concentration was determined by Lowry’s method (1951). 
Protein samples used for SDS-PAGE were prepared by incubating the lysate at 95°Cfor 
10 minutes, with loading buffer (6 x buffer: 0.2M Tris-HCl, 48% glycerol, 4% SDS, 2% 
β-mercaptoethanol, 0.2% bromophenol blue, pH 6.8). 
 
Electrophoresis: Samples were run in 7.5% and 10.0% SDS polyacrylamide gel at a 
constant current of 20mA/gel with an electrophoresis system (BioRad MiniProtean II) 
according to the Laemmli method (1970). Pre-stained protein standards (Bio-Rad 
161-0318) were used to monitor the protein separation during electrophoresis, which 
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indicated the efficiency of protein transfer to the membrane in the following immunoblots.   
 
Immunoblots: The proteins in the gel were blotted on a PVDF membrane pre-treated 
with 95% methanol. The blotting was conducted overnight at constant voltage 20V/gel in 
4°Ccold room in blotting buffer (25 mM Tris, 192 mM glycine, 20% Methanol) with a wet 
blot system (BioRad TransBlotCell)  
. 
After the transfer, the PVDF membrane was blocked by rinsing in 95% methanol for 
10 seconds, dried for 30minutes at RT, and then incubated in primary antibody solution 
(1.5% TopBlock reagent (VWR AG. Switzerland) in TBST containing 20 mM Tris, 150 mM 
NaCl and 0.1% Tween-20, pH 7.4 ) overnight at 4°C. Polyclonal antibodies R140 and R85 
against mouse calsyntenin-1 were diluted at 1:500 or 1:1000 for Western blots.  
 
R85 antibodies recognizing the cadherin domain in the extracellular part were 
produced by immunizing rabbits with the recombinant peptide containing 43-295 residues 
of murine calsyntenin-1. R140 antibodies were raised against several peptides from the 
cytoplasmatic part of murine calsyntenin-1. The anti-alpha-actin antibody (sigma) was 
used in Western blots to detect alpha-actin as a loading control. After washing 3 times with 
TBST at RT, the PVDF membrane was incubated in a secondary antibody solution (1.5% 
TopBlock reagent in TBST, HRP-conjugated goat-anti-rabbit IgG diluted at 1:20,000) for 1 
hour at RT. 
 
Detection of secondary antibody-bound protein was achieved with the Enhanced 
Chemiluminescent (ECL) substrate kit (SuperSignal WestPico, Pierce) or with a freshly 
prepared home-made HRP-ECL substrate. The home-made substrate was prepared by 
mixing Buffer A (0.25 mM Luminol/DMSO, 0.05 mM p-Cormaric acid/DMSO in 0.1 M 
Tris-HCl, pH 8.5) with Buffer B (0.02% H2O2 in 0.1 M Tris.Cl pH 8.5) in equal volumes. The 
PVDF membrane was incubated in the mixture for 10 minutes. The ECL emission was 
visualized and processed with a Fuji cooled CCD camera in Stella unit (Raytest, Germany) 
and combined software package. 
 
3.10 Immunocytochemistry 
 
Cells grown on coverslips were fixed for 10 minutes with 4% paraformaldehyde (PFA) 
in PBS (pH 7.4) containing 4% sucrose at RT, pre-incubated for 1 hour in blocking PBS 
supplemented with 10% FCS and 0.1% glycine at RT. The coverslips were exposed 
overnight to well-characterized primary antibodies diluted with PBS supplemented with 
3% FCS and 0.1% saponin at RT. (R140 diluted at 1:100, GM 130 diluted aqt 1:500). After 
washing with PBS containing 0.1% Tween-20, the cells were incubated in secondary 
antibodies in PBS supplemented with 3% FCS, 0.1% saponin for 1 hour at RT in dark. 
Secondary antibody G&R-Fitc/ D&G-Fitc/D&R-cy3/D&M-cy5 (Jackson Immuno-Research 
Laboratories) were diluted in 1:300 to 1:500. The coverslips were washed with PBS and 
mounted on glass slides with fluorescent mounting medium (DakoCytomation).  
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3.11 Immunohistochemistry on organotypic slices culture 
  
The cultures were washed 3 times with PBS, fixed with 4% PFA in 0.1 M PB buffer for 
10 minutes. After three washes with PBS, the cultures were incubated overnight at 4°C in 
0.1 M PB buffer supplemented with 30% sucrose solution and 12% glycerol. The cultures 
were frozen and thawed in dimethylbutane at -40~-50°C to increase the permeability to 
the antibodies. Then the cultured slices were removed from the cover slips or membranes 
with a brush. From then on, the culture was freely floating in the solution.  
 
The cultures were blocked in 10% horse serum in PBS for 1 hour and then incubated 
5 days in primary antibody solution (10% horse serum, 0.3% Triton-100, 1% NaN3 in PBS, 
antibody R140 diluted at 1:100.) at 4°C with a cold room shaker. After washing with PBS, 
the cultures were transferred into secondary antibody solution (10% horse serum, 0.3% 
Triton-100) and incubated overnight with a 4°C shaker. The cultures were thoroughly 
washed with PBS for 2 days with a 4°C shaker and then mounted onto glass slides with 
fluorescent mounting medium (DakoCytomation) and cover slips. 
 
3.12 Fluorescent microscopy  
 
Fluorescence of cells on coverslips was viewed with a fluorescent microscope 
(Axiophot, Carl Zeiss). Images were captured with a Zeiss camera AxioCam or Leica 
confocal microscope TCS-SP1. DAPI and Hoechst fluorescence of nuclei was captured 
by excitation at 330-380 nm with a 440 nm barrier filter. Cy3 fluorescence was visualized 
by excitation at 510-550 nm, with a barrier of 590 nm. Cy5 fluorescence was detected by 
excitation at 590-650 nm, with a barrier of 700 nm. FITC/GFP fluorescence was visualized 
by excitation at 470-490 nm, with a barrier of 520-580 nm. 
 
3.13 Morphological analysis 
 
Primary hippocampal neurons were plated at low density in 2x104cells/ml for 
morphological analysis. 10 days after the AAV infection, the cells were fixed in 4% PFA in 
PBS containing 4% sucrose for 10 minutes. After rinsing with PBS, coverslips were 
mounted onto glass slides with fluorescent mounting medium (DakoCytomation). 
 
For each treatment, 10 green fluorescent neurons were randomly selected from the 
microscopic fields and images were captured with a CCD video camera. The numbers of 
primary dendrites originating from neuronal soma and the secondary dendrite branches 
were counted to evaluate dendritic development. 
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3.14 NMDA-induced excitotoxicity in primary neuronal culture 
 
Primary neuronal cells infected with calsyntenin-1 overexpressing or down-regulating 
rAAV vectors were cultured on 12-well plates for more than 10 days before they were 
used for excitotoxic studies. The excitotoxic stress was induced by exposing the cells to 
100 µM NMDA for 30 minutes. To assess apoptotic responses of the cells to NMDA 
excitotoxicity, Hoechst staining assays were conducted 24 hours after the NMDA 
exposure to indicate nuclear condensation in apoptotic cells and apoptotic-like cells. 
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IV. Results and Discussion 
 
The most common method to study a new gene is to achieve and characterize 
loss-of-function and gain-of-function. Recently, vector-based siRNA has become a 
popular tool to investigate genes through the powerful and specific suppression of a 
particular gene. 
 
RNA polymerase III promoters have been widely used in DNA plasmid vectors to 
drive the expression of siRNAs to enable long-term gene inhibition of a targeted gene in 
mammalian cells.  
 
4.1 RNA polymerase III promoters isolated from mouse and human 
genomic DNA by PCR 
 
Among the RNA polymerase III promoters, the U6 and the H1 promoters are the best 
characterized, with the U6 promoter stretching several hundred base pairs but the H1 
promoter having a relatively short length of 100 base pairs. These two promoters give 
different patterns of amount and sub-cellular location of siRNAs expression in different cell 
types.  
 
The essential elements in mammalian U6 and H1 promoters are highly conserved so 
that human promoters can induce siRNA production efficiently in mouse cell lines. We 
cloned vectors with the mouse U6 promoter and additionally with human U6 and H1 
promoters. 
 
4.1.1 Mouse U6 promoter: 
GCGGATCCGACGCCGCCATCTCTAGGCCCGCGCCGGCCCCCTCGCACAGACT
TGTGGGAGAAGCTCGGCTACTCCCCTGCCCCGGTTAATTTGCATATAATATTTCC
TAGTAACTATAGAGGCTTAATGTGCGATAAAAGACAGATAATCTGTTCTTTTTAATA
CTAGCTACATTTTACATGATAGGCTTGGATTTCTATAAGAGATACAAATACTAAATTA
TTATTTTAAAAAACAGCACAAAAGGAAACTCACCCTAACTGTAAAGTAATTGTGTG
TTTTGAGACTATAAATATCCCTTGGAGAAAAGCCTTGTTAACGCTCTAGAGC 
 
4.1.2 Human U6 Promoter: 
GCCTCGAGAGGGCCTATTTCCCATGATTCCTTCATATTTGCATATACGATACAAGG
CTGTTAGAGAGATAATTAGAATTAATTTGACTGTAAACACAAAGATATTAGTACAAA
ATACGTGACGTAGAAAGTAATAATTTCTTGGGTAGTTTGCAGTTTTTAAAATTATGT
TTTAAAATGGACTATCATATGCTTACCGTAACTTGAAAGTATTTCGATTTCTTGGCT
TTATATATCTTGTGGAAAGGACGAAACACCTTTTTAAGCTTGGG 
 
4.1.3 Human H1 promoter: 
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GCCTCGAGATTTGCATGTCGCTATGTGTTCTGGGAAATCACCATAAACGTGAAAT
GTCTTTGGATTTGGGAATCTTATAAGTTCTGTATGAGACCACTCTTTCCCTTTTTA
AGCTTGGG 
 
Previous studies (Seppo.YH, J.Gene.Med 2006) showed that the U6 promoter is 
more efficient than the H1 promoter in gene silencing in mouse cells in vitro and in vivo. 
Our siRNA vector construction was based mainly on the vector containing the mouse U6 
promoter. 
  
4.2 Summary of siRNA constructs against EGFP and mouse calsyntenins 
 
In the hairpin-type siRNA construct, the RNA polymerase III promoter U6 produces 
small transcripts extending from a well-defined start to a 5T–in-row terminal. Once the 
siRNA is transcribed, its reverse complementary part folds back immediately to bind tightly 
to the sense fragment, giving rise to a hairpin structure, which mimics the natural RNA 
intermediate in the RNA interference pathway and eventually induces a 
sequence-dependent transcriptional inhibition mediated by RISC (Figure 4.1). 
 
 
 
 
 
Figure 4.1: Schematic illustration of a hairpin-type siRNA transcribed from a 
U6-driven vector 
  A: Design of two complimentary oligonucleotides 
 B: siRNA generated by a hairpin-type siRNA cassette: The siRNA transcripts fold back to bind 
tightly with the complementary sequences to form hairpin structure, which mimic the natural RNA 
intermediate in the RNA interference pathway. 
 
19nt sense 19nt antisense
CTTTTT 
C G
spacer
AAAAA 5
3
A 
TTTTT
uuuu
U6 promoter
sense antisense B 
Ph.D Thesis 
 
  63 
 
GCGGATCCGACGCCGCCATCTCTAGGCCCGCGCCGGCCCCCTCGCACAGACT
TGTGGGAGAAGCTCGGCTACTCCCCTGCCCCGGTTAATTTGCATATAATATTTCCTAG
TAACTATAGAGGCTTAATGTGCGATAAAAGACAGATAATCTGTTCTTTTTAATACTAGCT
ACATTTTACATGATAGGCTTGGATTTCTATAAGAGATACAAATACTAAATTATTATTTTAA
AAAACAGCACAAAAGGAAACTCACCCTAACTGTAAAGTAATTGTGTGTTTTGAGACTA
TAAATATCCCTTGGAGAAAAGCCTTGTTT(GGAGCTGTTCACCGGGGTG)TTCAAGAG
A(CACCCCGGTGAACAGCTCC)TTTTTTAACGCTCTAGAGC  
pBlueU6-siEGFP.1 targeting EGFP gene 18-37bp 
 
(GCCCACCCTCGTGACCACC)TTCAAGAGA(GGTGGTCACGAGGGTGGGC)TTTTT 
pBlueU6-siEGFP.2 targeting EGFP gene 173-192bp 
 
(GCGTGCAGCTCGCCGACCA)TTCAAGAGA(TGGTCGGCGAGCTGCACGC)TTTTT 
pBlueU6-siEGFP.3 targeting EGFP gene 536-545bp 
 
(GGTGAACGACGTGAACGAG)TTCAAGAGA(GTCGTTCACGTCGTTCACC)TTTTT 
pBlueU6-siCst1.1 targeting mouse calsyntenin-1 458-476bp 
 
(GGCTGTCTTCCCGAGCATC)TTCAAGAGA(GATGCTCGGGAAGACAGCC)TTTTT 
pBlueU6-siCst1.2 targeting mouse calsyntenin-1 842-860bp 
 
(GGACCCGTCTGAGGAGAG)TTCAAGAGA(CTCTCCTCAGACGGGTCC)TTTTT 
pBlueU6-siCst1.3 targeting mouse calsyntenin-1 1298-1316bp 
 
The vector pBlueU6-siNonsense, producing siRNA transcripts that do not target any 
mammalian gene, is designed as a control to validate the specificity of the RNA 
interference. 
(GGCATACCGCCCCGGGATG)TTCAAGAGA(CATCCCGGGGCGGTATGCC)TTTTT 
The target sequence of nonsense siRNA is derived from rice genome (Oryza sativa: 
EF576615.1). 
 
siRNA targeting different sites of the same gene demonstrates strikingly different 
gene silencing efficiency. This positional effect may relate to the different accessibility of 
the siRNA to target sites on mRNA. Up to now, no clear correlation between target 
sequence and siRNA potency has been revealed except for a slight bias to lower GC 
content (about 40%) within the target sequence. Multiple sites were usually selected 
randomly along the target gene sequence to construct a pool of siRNA plasmids, which 
was then screened for the most effective one. Statistically, only one fourth of siRNA 
plasmids against a particular gene result in significant reduction in gene expression. 
 
The specificity of the siRNA is exclusively sequence dependent, which means single 
nucleotide mutations in siRNA sequence may abolish the gene silencing effect. To ensure 
the specificity of the siRNA, potential target sites were screened with an appropriate 
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genome database www.ncbi.nlm.nih.gov/BLAST to avoid homology to other functional 
coding sequences. Moreover, all of the siRNA plasmids were proofread repeatedly by 
PCR sequencing. 
 
Unfortunately, in many cases chromatography shows that the sequencing reaction 
was quelled at the start region of the siRNA sequence. This can be explained by the fact 
that the strong secondary structure in the siRNA hairpin is extremely difficult to sequence 
by the PCR sequencing method. (Figure 4.2) 
 
 
 
ACCTTGGAGAAAAGCCTTGTTTGCGTGCAGCTCGCCGACCAttcaagagaTGGTCGGC
GAGCTGCACGC)TTTTT 
 
Figure 4.2: Sequencing quelled at siRNA region 
 
We have had success in breaking through the siRNA hairpin regions by using a 
combination of addition of DMSO to a final concentration of (v/v) 10% and 
pre-denaturation of template DNA at 96°C for 5 minutes before PCR sequencing. But both 
the addition of DMSO and the pre-denaturation impaired the performance of the DNA 
polymerase in the reaction system, leading to inaccurate base identification and even total 
shut down of the reaction.  
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To circumvent these sequencing obstacles, tandem-type siRNA constructs were 
designed and cloned. In this system, no strong secondary structure was formed between 
the sense and antisense sequence of the siRNAs since they were cloned separately and 
under the control of different RNA polymerase III promoters. The individually transcribed 
RNA strands were predicted to bind to each other to form double-stranded RNA, which 
could be further transformed in the RNA interference pathway, leading to target gene 
silencing. (Figure 4.3) 
 
 
 
 
 
 
 
 
 
 
 
 
Figure4.3: Schematic illustration of siRNA generated by the U6-driven 
tandem-type siRNA vector 
In tandem-type siRNA system, no strong secondary structure was formed between the sense and 
antisense sequence of the siRNAs since they were cloned separately and under the control of 
different RNA polymerase III promoters. The individually transcribed RNA strands anneal to each 
other to form active siRNA duplex, which could be transformed in the RNA interference pathway, 
leading to target gene silencing. 
 
One tandem type siRNA construct pBlueU6-siEGFP-T was cloned to target the EGFP 
gene at 173-192bp. 
GCCCACCCTCGTGACCACC TTTTT sense strand 
GGTGGTCACGAGGGTGGGCTTTTT antisense strand 
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4.3 Testing with EGFP 
 
Initially, a series of siRNA vectors against enhanced green fluorescent protein (EGFP) 
were designed and constructed to validate our vector-based siRNA system in mammalian 
cells. siRNA vectors against the EGFP gene, such as pBlueU6-siEGFP.1 etc. were 
co-transfected with EGFP expressing vector pEGFP-N1 into HEK293T cells using the 
lipofactamine 2000 reagent. The intensity of green fluorescence provided a direct 
evaluation of the EGFP expression level when visualized with fluorescent microscopy. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.4: Silencing co-transfected EGFP expression in HEK293T cell lines by 
siEGFP gene transfer 
siRNA plasmids targeting the EGFP gene were co-transfected with EGFP expressing vector 
pEGFP-N1 into HEK293T cells using the lipofactamine 2000 reagent. The intensity of green 
fluorescence provided a direct evaluation of the EGFP expression level when visualized with 
fluorescent microscopy. 
A: normal light  
B: green fluorescent: The intensity of green fluorescence indicates the EGFP expression level 
which is negatively proportional to knockdown efficiency of the corresponding siRNA plasmid. 
 
 
As shown in figure 4.4, the reduction of green fluorescence intensity indicated that 
pBlueU6-siEGFP.1 
Background 
pBlueU6-siEGFP.2 
pBlueU6-siEGFP.3 
pBlueU6-siNonsense 
pEGFP-N1  + 
siEGFP.1 
EGFP Gene 
siEGFP.2 siEGFP.3 
A B 
6 
5 
4 
3 
2 
1 
Negative control 
Ph.D Thesis 
 
  67 
EGFP expression was down-regulated by all three siEGFP constructs at different levels 
when normalized with green fluorescence intensity in the siNonsense control, which 
showed no obvious interference of EGFP expression. The pBlueU6-siEGFP2 targeting 
EGFP gene 173-192bp demonstrated the most efficient EGFP reduction. (Figure 4.4)  
 
The lipofectamine 2000 reagent could achieve 97% transfection efficiency in 
NG108-15 cells when determined by flow cytometry, offering a powerful tool to deliver 
plasmid DNA into cell lines. The hairpin-type construct pBlueU6-siEGFP.2, its derivative 
pBlue6-siEGFP-m that has a single nucleotide mutation in siRNA sequence, and the 
tandem-type construct pBlueU6-siEGFP-T were co-transfected with the EGFP-expressing 
vector pEGFP-N1 into NG108-15 cells, respectively. (Figure 4.5) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.5: Silencing EGFP expression in the NG-108 cell line by siEGFP gene 
transfer 
siRNA plasmids targeting the EGFP gene were co-transfected with EGFP expressing vector 
pEGFP-N1 into NG-108 cells using the lipofactamine 2000 reagent. The intensity of green 
fluorescence provided a direct evaluation of the EGFP expression level when visualized with 
fluorescent microscopy. 
A: normal light  
B: green fluorescence: The intensity of green fluorescence indicates the EGFP expression level 
which is negatively proportional to knockdown efficiency of the corresponding siRNA plasmid. 
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Even derived from the same target sequence, the hairpin-type siEGFP suppressed 
EGFP expression more efficiently than the tandem-type siEGFP in this case. The mutant 
derivative pBlueU6-siEGFP-m shows significant sabotaged ability of target gene silencing 
compared with the fully-sequence-matched pBlueU6-siEGFP.2, suggesting the strict 
sequence dependent specificity of the siRNA system. 
 
To exclude the possibility that the EGFP reduction is due to the interference during 
gene transfection, the cultures transfected with pBlueU6-siEGFP.2 were examined with 
over-exposure at 3000 ms to detect the reduced green fluorescence. The results 
demonstrated that the transfection of EGFP-expressing vector pEGFP-N1 was successful. 
EGFP expression was generally suppressed in the cells by siEGFP (Figure 4.6). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.6: Silencing EGFP expression in the NG-108 cell line by siEGFP gene 
transfer. 
siRNA plasmids targeting the EGFP gene were co-transfected with EGFP expressing vector 
pEGFP-N1 into NG-108 cells using the lipofactamine 2000 reagent. The intensity of green 
fluorescence provided a direct evaluation of the EGFP expression level when visualized with 
fluorescent microscopy. 
A: Normal light; B: Green fluorescence (30 ms);  
C: Green fluorescence overexposure (3000 ms) 
The intensity of green fluorescence indicates the EGFP expression level which is negatively 
proportional to knockdown efficiency of the corresponding siRNA plasmid. 
1: control;  
2: pEGFP-N1 transfection;  
3: Co-transfection of pEGFP-N1 and pBlueU6-Nonsense; 
4: co-transfection of pEGFP-N1 and pBlueU6-siEGFP-2 
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The efficiency of EGFP suppression by siRNA was determined with flow cytometry. 
The percentage of EGFP positive cells was recorded and calculated, giving a 60% 
reduction of EGFP positive cells with pBlueU6-siEGFP.2 when normalized to the control 
pBlueU6-siNonsense (Figure 4.7). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
: 
 
 
 
 
 
 
 
Figure 4.7: Determining silencing efficiency of EGFP expression with flow 
cytometry 
The efficiency of EGFP suppression by siRNA was determined with flow cytometry. The percentage 
of EGFP positive cells was recorded, calculated and normalized with pBlueU6-nonsense control.   
A: Background control 
B: EGFP expression 
C: siRNA against EGFP 
D: Nonsense siRNA control 
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4.4 Down-regulating co-transfected calsyntenin-1 expression in the 
NG108-15 cell line 
 
siRNA constructs against calsyntenin-1 were tested in the NG-108 cell line by 
co-transfection with the calsyntenin-1 over-expressing vector pcDNA3.1-mmCst1. 
Immunoblotting with the polyclonal antibody R140 recognizing the cytoplasmic part of 
calsyntenin-1 revealed that co-transfected calsyntenin-1 expression was suppressed to 
undetectable levels by pBlueU6-siCst1.1 (Figure 4.8). 
 
The specificity of the knockdown was validated with the nonsense control 
pBlueU6-siNonsense, which did not show obvious interference to calsyntenin-1 
expression. The data were normalized to endogenous housekeeping gene alpha-actin 
expression as aninternal control to validate the experiment.  
 
 
Figure 4.8: Down-regulation of co-transfected calsyntenin-1 by the 
corresponding siRNA in the NG-108 Cell Line 
 1: control  
 2: pcDNA3.1-cst1 co-transfected with pBlueU6-siCst1-1 
 3: pcDNA3.1-cst1 co-transfected with pBlueU6-nonsense 
 
Endogenous calsyntenin-1 and 3 expressions in NG108-15 cells were detected at the 
transcriptional level with RT-PCR. Calsyntenin-2 expression could not be detected with 
this method. But the expression level of calsyntenin-1 and 3 in this cell line is very low and 
beyond the sensitivity of immunoblotting detection. 
 
A semi-quantitative RT-PCR method was developed to examine calsyntenin 
down-regulation using mRNA normalized to the housekeeping gene GAPDH. However, 
many highly variable factors involved in the method could affect the accurate reflection of 
gene activity, resulting in unstable and irreproducible readouts (data not shown). 
 
To date, the factors affecting the potency of the vector-based siRNA system to knock 
down endogenous calsyntenin remain unclear. In the future, quantitative real-time 
RT-PCR, a well-established and sensitive approach to quantify specific mRNA abundance, 
could be used to evaluate siRNA-mediated calsyntenin silencing at the mRNA level. 
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α-actin 
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4.5 Primary hippocampal neuronal culture  
 
Cultured neurons develop both morphologically and functionally in dissociated 
primary neuronal culture, providing a simplified and easily accessible in vitro model to 
investigate the properties and functions of neurons. The highly preserved key phenotypic 
features such as polarity and synaptic connections represent advantages over continuous 
neuronal cell lines for this type of research. 
 
The hippocampus is the most commonly used structure in preparing neuronal 
cultures since its well-defined structure can be easily isolated from the brain and its 
relatively simple cell populations, with a vast majority of pyramidal cells dominating over 
many fewer interneurons, giving a relatively homogenous culture. Over several decades, 
intensive studies have provided a comprehensive understanding of the many features of 
hippocampal neurons in the culture, offering helpful guidelines to new experiments. 
 
Dissociated neuronal cultures were prepared from hippocampi of embryonic 
18-day-old mouse. Cells were cultured on poly-L-lysine coated coverslips in chemically 
defined medium. Low-density cultures with widely spaced cells are ideal for imaging and 
morphological studies. High-density cultures are often prepared for biochemical anaylsis 
such as immunoblotting and immunopercipitation (Figure 4.9). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.9: Dissociated primary hippocampal neuronal culture growing on 
coated coverslips at a low-density 
The dissociated primary hippocampal neuronal culture prepared from E17-18-day-old mouse which 
grow on the poly-L-lysine coated coverslips for 14 days, exhibiting preserved morphological 
features.  
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Consistent calsyntenin-1, -2 and -3 expressions were detected with RT-PCR in 
mouse primary hippocampal neuronal culture (Figure 4.10). 
 
 
 
 
 
 
 
 
Figure 4.10: RT-PCR for calsyntenin expression profile with total RNA prepared 
from mouse primary hippocampal neuronal culture 
Calsyntenin-1, -2,-3 are expressed in mouse primary hippocampal neuronal cultures  
4.6 Organotypic hippocampal slice culture 
 
The organotypic culture is an in vitro system in which differentiated cells closely 
resemble their in vivo counterparts, offering a possibility to establish easy-to–manipulate 
and biologically meaningful 3-dimensional models with well-preserved structure and 
function in a native-like configuration. The principle neuronal populations, pyramidal 
neurons and granule cells, are well-characterized in hippocampal slice cultures. Also, the 
connectivity of the neurons in culture has been well characterized in previous studies. 
Therefore, the hippocampal slice culture has been widely used to investigate many 
aspects of neuronal function, such as neuronal development, electrophysiological 
properties and pathology.   
 
Following the method developed by Stoppini et al in 1991, hippocampal slice cultures 
were prepared from postnatal 6-day-old neonates and maintained on semi-permeable 
membranes in culture at the interface of a humidified atmosphere and medium. When 
plated, the slices spontaneously attach to the membrane and flatten down to about 100 
μm in thickness from the original 300 μm within a few days. In Nissl-stained culture, 
sub-regions such as the dentate gyrus (DG), CA1 and CA3 are highly distinguishable from 
each other, demonstrating histological preservation and integrity (Figure 4.11). 
 
 
 
 
 
 
 
 
 
 
Figure 4.11: Nissl-stained organotypic hippocampal slice culture 
The Nissl-stained hippocampal slice culture shows histological preservation and integrity. 
M1 1 2 3 4 M2 
M1: marker 1 
1: Calsyntenin-1 
2: Calsyntenin-2 
3: Calsyntenin-3 
4: GAPDH 
M2: marker 2 
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Immunoflorenscence staining with the antibody R140 and the neuronal marker NeuN 
reveals the calsyntenin-1 expression profile in mouse hippocampal slice culture, with the 
neurons in CA3 region showing the strongest calsyntenin-1 distribution (Figure 4.12). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.12 Calsyntenin-1 expressions in mouse organotypic hippocampal 
slice culture 
Blue: NeuN neuronal marker that stains the nuclei of neurons 
Red: Mouse calsyntenin-1 detected with the R140 antibody 
 
NeuN R140 
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4.7 The attempts to transduce neurons in primary neuronal culture and 
organotypic slice culture 
 
To deliver the siRNA cassettes into neurons in culture, we first tried several nonviral 
approaches, which are considered less time-consuming and do not require complicated 
molecular biological facilities for their application.  
 
It is well known that the post-mitotic, terminally differentiated neurons are among the 
most difficult cell types to be transduced by foreign genetic materials. The routinely used 
non-viral methods for cell transfection such as liposome reagents, electroporation, 
biolistics (gene gun) all encountered significant problems in neurons, resulting in poor 
efficiency of gene delivery. We followed a protocol for transfection with the lipofectamine 
2000 reagent at a low concentration, which has been reported to achieve high throughput 
gene delivery consistently in primary neurons. Transfection efficiency was evaluated 3 
days later when the transfected cells were indicated by the green fluorescence of the 
EGFP marker. In our experience, Lipofectamine 2000 achieved only 10% transfection 
efficiency within the surviving cells, and the lifespan of the transduced neurons was 
drastically reduced to about 1 week. In addition, obvious morphological disruption, such 
as reduced neuronal dendritic branching, was observed in most of the neurons (Figure 
4.13).  
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.13: Lipofectamine 2000 transfection in primary hippocampal neuronal 
culture 
Lipofactamine 2000 achieves very low transfection efficiency in primary neuronal cultures. 
Obvious morphological disruption such as reduced neuronal dendritic branching was observed 
in most of the cells. 
EGFP Merge R140 
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Electroporation is a mechanical delivery approach that works by transiently 
increasing the permeability of the cell membrane with externally applied electrical current. 
In the strong pulsing electrical field, the plasma membrane is temporarily disturbed, 
allowing the foreign compounds to enter the cell.  
 
Based on the description of the electroporation device that have been used to 
successfully transfer DNA into mouse brain tissues (Weaver, 1995), we set up an 
electroporation system with a pair of home-made plate-like electrodes and a pulse 
generetor (BTX products). A constant and evenly distributed electrical field was generated 
between the parallel electrodes when current was applied (Figure 4.14). 
 
 
 
 
 
 
 
 
Figure 4.14: Measurement of electrical field distribution and density 
 
After pulsing hundreds of slices, we found that the method is not applicable for 
organotypic cultures because of its low efficiency, poor reproducibility and unclear cellular 
specificity. In our experience, only few cells, mainly located in the marginal region of the 
slice culture, were transduced (Figure 4.15). 
Additionally, cell damage and even tissue rupture were observed frequently after 
electroporation. 
 
 
 
 
 
 
 
 
 
 
Figure 4.15: Electroporation in an organotypic hippocampal slice culture 
Electroporation achieves very low efficiency and poor reproducibility in tranducing hippocampal 
slice cutures. Only few cells located in the margin eare were transduced without any cellular 
specificity. Cell damage and tissue rupture were generally observed after the manipulation. 
 
Recently, advanced electroporation techniques such as the cellaxess CX1 capillary 
have become commercially available as a potential tool offering higher competency to 
introduce genes into cells in organotypic slice cultures.  
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4.8 Recombinant adeno-associated virus vector 
 
Frustrated by the electroporation and liposome delivery system, we switched our 
efforts to setting up a viral vector system, which may allow better transduction in neurons. 
Compared with other viral vectors being used in gene delivery, recombinant 
adeno-associated vector (rAAV) is distinguished by its outstanding efficiency to transduce 
post-mitotic neurons long-term efficacy, safety and, most importantly, the minimal 
disturbance of the host gene expression profile. The stable integration of the AAV vector 
into the host genome allows persistent transgenic expression. The fact that the AAV 
vector is not associated with human pathology because it cannot replicate allows all the 
experiments to be conducted in ordinary laboratory settings. Additionally, rAAV vectors 
and the methods of preparation are well-established, permitting straightforward 
implementation of the technique. 
 
Briefly, the generation of recombinant AAV vectors employs the complete 
replacement of the wild type AAV genome with genes of interest flanked by two 145bp 
viral ITR (Inverted Terminal Repeats) sequences that contain signals for packaging. When 
the recombinant AAV plasmids were co-transfected with the helper plasmid pDG, which 
contains genes encoding AAV structural capsid proteins and other proteins necessary for 
viral packaging, the ITR could be specifically recognized and recruited by the viral capsid, 
leading to efficient packaging of the transgene into the infectious virus. The cloning 
capacity of the AAV subtype 2 vector is limited to approximately 5.0kb of DNA.  
 
ITR sequences also carry the signals involved in virus integration, allowing the 
transgene cloned between the two ITRs integrated into the host genome to achieve stable 
long-lasting expression. 
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4.8.1 AAV infection of hippocampal slice cultures 
We tested the efficiency of AAV infection in slice cultures by simply adding the 
solution containing a recombinant AAV vector carrying an EGFP maker into the medium 
immediately after the preparation of the slices. 10 days after the infection, large numbers 
of green fluorescent cells were detectable (Figure 4.16). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.16: AAV infection in a hippocampal slice culture.  
AAV vector carrying EGFP reporter shows promising transfection efficiency in subregions CA1 
and CA3 of hippocampal slice culture.  
CA3 region CA1 region 
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To evaluate cell tropism associated with AAV infection in slice cultures, an antibody 
against the neuronal marker NeuN was used for immunofluorescence staining to identify 
neurons. As shown below, only few NeuN positive cells overlapped with EGFP fluorescent 
cells, suggesting that most of AAV infected cells are not neurons (Figure 4.17). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.17: AAV infection in a hippocampal slice culture 
Neurons indicated by neuronal marker NeuN do not show much overlap with the cells expressing 
AAV-introduced EGFP reporter. Calsyntenin-1 indicated by R140 antibody is mainly expressed in 
pyramidal neurons. 
 
A previous study (Ehrengruber, M.U., 2001) of a vector derived from Semliki forest 
virus (SFV) demonstrated high transduction of neurons in hippocampal slice cultures, but 
the method can only be used for short-term studies since the viability of infected cells was 
drastically reduced because of virus-induced cytotoxicity at 7 days after the infection. 
 
In addition, the Biolistic technique (biological ballistics) has been used successfully to 
deliver DNA into neurons in organotypic slice cultures by shooting DNA-coated gold 
particles directly into cells (McAllister.A.K, 2000). But this approach is limited by its low 
cellular specificity and the requirement of costly instruments. 
NeuN 
EGFP 
Merge 
R140 
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4.8.2 AAV infection in primary neuronal cultures 
Fortunately, the AAV approach demonstrated very promising infection patterns in 
primary hippocampal neuronal cultures when tested with the AAV-CMV-EGFP vector. In 
optimized conditions, the transfection efficiency could reach as high as 90%.  
 
AAV was applied to the medium immediately after the neurons were plated. The 
green fluorescent cells could be detected under the microscope at 7 days after infection. 
The high-grade EGFP expression was sustained for 6 weeks until neurons in the culture 
died (Figure 4.18). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.18: AAV infection in primary hippocampal neuronal cultures 
Green fluorescence of EGFP reporter can be detected in primary hippocampal neuronal 
culture 7 days after infection.  
] 
In our experience, rAAV proved to be a highly versatile transfection vector in primary 
neuronal cultures resulting in stable and long-term expression after a single 
administration. 
20 days culture 7 days culture 
 7  0  20 Culturing time (days) 
 AAV infection 
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4.8.3 Construction of an AAV-siRNA vector with an EGFP marker 
 
The parent vector psubAAV2-CMV-WPRE was used to construct the AAV vectors to 
express siRNAs.  
 
First, the cassette for EGFP expression was isolated from pEGFP-N1 and 
subsequently cloned into the AAV vector, giving a marker for infected cells. The resulting 
psubAAV2-CMV-EGFPN1 plasmids were screened with RE analysis and further analyzed 
by transfection into HEK293T. Green fluorescence was detectable at 24 hours after 
transfection.  
 
AAV particles were produced according to the preparation and purification methods 
described above. The HEK293T cells infected with AAV particles AAV-CMV-EGFPN1 
efficiently expressed EGFP, which was detectable with fluorescent microscopy at 72 hours 
after infection, demonstrating that the AAV particles we prepared were active and 
infectious. (Figure 4.19) 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.19: HEK293T cell infected with AAV2-CMV-EGFPN1 
HEK293T cells offer a quick and easy testing for the infectiosity and activity of recombinant AAV 
carrying EGFP reporter. Green fluorescence of EGFP reporter can be detected 72 hours after 
infection. 
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Next, siRNA cassettes were transferred from previous pBluescript-based siRNA 
constructs into AAV vectors to form the AAV vector-based siRNA constructs. In this vector, 
EGFP expression is regulated by the CMV promoter while siRNA transcription is 
controlled independently by U6 promoter. (Figure 4.20) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.20: AAV-siRNA vector containing an EGFP marker 
AAV vector containing EGFP marker shows successful infection in the neurons in primary neuronal 
culture. Golgi marker serves as the indicator of the cell body of the neurons. The cartoon 
schematically outlines U6 promoter driven siRNA expression AAV vector carrying the CMV 
promoter driven EGFP marker.
ITR ITR EGFP siRNA pU6 
Phase contrast EGFP
Golgi Marker
(GM130)
Cst-1
(R140)
pCMV 
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4.8.4 AAV vector containing the EGFP-2A fusion frame 
 
The major disadvantage of the rAAV vector is the limited cloning capacity, which 
allows only approximately 5.0kb of transgenic DNA to be packaged into the viral 
genome. When we tried to obtain calsyntenin and EGFP marker co-expression in the 
AAV vector, it became problematic because the two transcription units exceeded the 
limitation of AAV packaging ability.  
 
The usage of the 2A sequence derived from the foot and mouse disease virus 
(FMDV) allows the bi-cistronic transcription from a single ORF (Open Reading Frame) 
unit encompassing the coding sequence of both peptides linked by the short 
sequence-encoding 2A peptide. Once translated, the 2A peptide leads to the 
separation of the two proteins by self-cleavage on its own C-terminal. The 2A 
sequence is rather short extending only for 48nt, which makes it extremely suitable 
for cloning multiple genes into the AAV vector.  
 
ATGGTGAGCAAGGGCGAGGAGCTGTTCACCGGGGTGGTGCCCATCCTGGTCG
AGCTGGACGGCGACGTAAACGGCCACAAGTTCAGCGTGTCCGGCGAGGGCGA
GGGCGATGCCACCTACGGCAAGCTGACCCTGAAGTTCATCTGCACCACCGGCA
AGCTGCCCGTGCCCTGGCCCACCCTCGTGACCACCCTGACCTGGGGCGTGCA
GTGCTTCAGCCGCTACCCCGACCACATGAAGCAGCACGACTTCTTCAAGTCCG
CCATGCCCGAAGGCTACGTCCAGGAGCGCACCATCTTCTTCAAGGACGACGGC
AACTACAAGACCCGCGCCGAGGTGAAGTTCGAGGGCGACACCCTGGTGAACC
GCATCGAGCTGAAGGGCATCGACTTCAAGGAGGACGGCAACATCCTGGGGCAC
AAGCTGGAGTACAACTACATCAGCCACAACGTCTATATCACCGCCGACAAGCAG
AAGAACGGCATCAAGGCCAACTTCAAGATCCGCCACAACATCGAGGACGGCAG
CGTGCAGCTCGCCGACCACTACCAGCAGAACACCCCCATCGGCGACGGCCCC
GTGCTGCTGCCCGACAACCACTACCTGAGCACCCAGTCCGCCCTGAGCAAAGA
CCCCAACGAGAAGCGCGATCACATGGTCCTGCTGGAGTTCGTGACCGCCGCC
GGGATCACTCTCGGCATGGACGAGCTGTACAAGAATTTTGACCTTCTTAAGCTT
GCGGGAGACGTCGAGTCCAACCCTGGGCCC(Apa I)GC  
 
The coding sequences of calsyntenins will be cloned downstream to the 2A 
sequence by insertion into the Apa I site.   
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4.9 Knockdown of endogenous calsynetnin-1 in primary neuronal 
cultures 
 
When evaluated by immunoblotting, all three AAV vectors expressing siRNA directed 
against mouse calsyntenin-1 gene successfully reduced the endogenous calsyntenin-1 
expression in primary neuronal cultures. The gene knockdown is specific as validated by 
expression of the housekeeping gene alpha-actin as a loading control.   
 
 
 
 
  
 
 
 
 
Figure 4.21: Screening of AAV-EGFP-siCst1 vectors for calsyntenin-1 silencing 
in primary neuronal cultures 
AAV vector containing different siRNA cassette targeting calsyntenin-1 shows distinguishable 
difference in the knockdown efficiency of calsyntenin-1 expression. The AAV-EGFP-siCst1.1 
achieves the excellent target gene silencing effect while AAV-EGFP-siCst1.2 AAV-EGFP-siCst1.3 
shows moderate or slight inhibition of calsyntenin-1 expression.   
 
The AAV-EGFP-siCst1.1 which targets the calsyntenin-1 gene at 458-476bp achieved 
the most striking target gene silencing effect, while the AAV-EGFP-siCst1.3 targeting at 
1298-1316bp showed slight inhibition. That siRNA vectors targeting different sites along 
the calsyntenin-1 gene achieved gene knockdown of different levels can be explained by 
the positional effect of siRNA (Figure 4.21). 
 
The calsyntenin-1 expression levels in AAV infected cultures were assessed by 
immunoblotting, followed by quantitative measurement with densitometry (ImageJ 
software, http://rsb.info.nih.gov/ij/). 
 
Relative mouse calsyntenin-1 expression in recombinant AAV infected primary neuronal 
cultures was normalized against the loading control alpha-actin. Taking the calsyntenin-1 
level in control virus AAV-EGFP-siNonsense treated culture as 100%, the expression 
levels of the full length and the stump of calsyntenin-1 in AAV-EGFP-siCst1.1-treated 
cultures were reduced to 19.2% and 35.9%, respectively (Figure 4.22). 
 
1: AAV-EGFP-siCst1.1 
2: AAV-EGFP-siCst1.2 
3: AAV-EGFP-siCst1.3 
4: AAV-EGFP-siNonsense 
1 2 3 4 
Full length calsyntenin-1 
Loading control 
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Figure 4.22: Efficiency of calsyntenin-1 knockdown in primary neuronal 
cultures with AAV-EGFP-siCst1.1 
AAV vector AAV-EGFP-siCst1.1 achieves target gene silencing effect in primary neuronal culture. 
The efficiency of calsyntenin-1 knockdown was evaluated by immunoblotting, showing the 
expression level of full length and the stump of calsyntenin-1 were reduced to 19.2% and 35.9% 
respectively. 
 
In order to further improve the knockdown potency of siRNAs, the loop sequence 
could be replaced by the one derived from endogenously expressed miRNA, which could 
facilitate the export of siRNA from the nucleus to the cytoplasm to form an active siRNA 
duplex (Haibin.X, 2004). 
 
Moreover, modified promoters derived from RNA polymerase type III or type II 
promoters such as the tetracycline-responsive H1 promoter and the enhanced CMV 
promoter, enable more effective or conditional siRNA suppression of target genes. 
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Calsyntenin knockdown in primary neuronal cultures infected with targeting 
rAAV-siRNA vectors was further assessed with immunofluorescence. Our results indicate 
significantly suppressed calsyntenin-1 expression in AAV-EGFP-siCst1 infected neurons 
when general gene expression was normalized to Golgi Marker expression (Figure 4.23). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.23: Calsyntenin-1 knockdown in primary neuronal cultures with 
AAV-EGFP-siCst1.1 
AAV vector AAV-EGFP-siCst1 significantly suppressed calsyntenin-1 expression in primary 
hippopcampal neuronal culture when the calsyntenin-1 expression levels were assessed with 
immunofluorescence and normalized to Golgi Marker levels.   
 
After repeated experiments and time-course studies, we came to the conclusion that 
Phase contrast Golgi Marker(GM130) EGFP Cst-1(R140) 
AAV-EGFP-siCst1.1 
AAV-EGFP-siNonsense (control)
AAV-EGFP-siNonsense (control)
AAV-EGFP-siCst1.1 
Phase contrast Golgi Marker(GM130) EGFP Cst-1(R140) 
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calsyntenin-1 down-regulation in primary hippocampal neuronal cultures are specific, 
stable, long-lasting and highly reproducible. 
 
4.10 Preliminary morphological studies 
 
rAAV treated neurons were fixed and visualized with fluorescent microscopy 15-20 
days after the AAV infection. 9 neurons with at least 4 primary dendrites arising from the 
soma were randomly selected from 6 cover-slips in each group. The number of primary 
dendrites for each neuron were counted and recorded. For statistical analysis, the 
average primary dendritic number was calculated for each group and subsequently used 
to perform a T-test with Microsoft Excel software to compare the formation of primary 
dendrites. Correlations were calculated by linear regression analysis. A P value < 0.05 
was considered significant. The results demonstrated that the AAV-EGFP-siCst1 infection 
did not induce significant changes in primary dendrite generation when compared with the 
control group treated with AAV-EGFP-siNonsense (Figure 4.24). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.24: Assessment of primary dendrite number in neurons 
AAV vector AAV-EGFP-siCst1 which significantly suppressed calsyntenin-1 expression in 
primary hippopcampal neuronal culture doesn’t show detectable changes in primary dendritic 
generation when compared with the control vector AAV-EGFP-nonsense.   
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Dentritic branching patterns have great impact on neuronal function, representing a 
major aspect of neuronal morphology. Neurons make two types of neuronal extensions: 
axons that send outputs to other neurons, and dendrites, that are specialized for receiving 
and processing inputs. The morphological pattern of the dendrites is quite variable from 
one type of neuron to another, permitting differential contributions to informational 
processing. Moreover, morphological changes often reflect functional disorders.  
 
4.11 Calsyntenin and excitotoxic neuronal death in vitro 
 
To answer the question whether calsyntenins are involved in excitotoxicity, a 
NMDA-induced apoptotic and necrotic neuronal death model was used to study the 
consequences of excitotoxic stress when applied to calsyntenin knockdown cultures. 
  
Mouse primary hippocampal neuronal cells infected with calsyntenin-1 
down-regulating vector AAV-EGFP-siCst1 were cultured on a 12-well plate for more than 
10 days before they were used for experiments. The excitotoxic stress was induced by 
exposing the cells to 100 µM NMDA for 30 minutes. To assess neuronal cell death, 
Hoechst staining assays were conducted at 24 hours after NMDA exposure to indicate 
nuclear condensation in apoptotic cells and necrotic cells as small bright dots (Figure 
4.25). 
 
Neurons from 10 randomly selected separate fields from 4 cover-slips in each group 
were counted, giving the percentage of apoptotic plus necrotic cells in total cells. Using 
Prism software, One-way Analysis of Variance (ANOVA) was performed to compare the 
percentage of apoptotic and necrotic cells. Correlations were calculated by linear 
regression analysis. A P value < 0.05 was considered significant. 
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Figure 4.25: Assessment of NMDA-induced apoptotic and necrotic cell 
death in primary neuronal cultures 
Assessed with Hoechst staining for apoptotic and necrotic neuronal cell death, the neurons 
transduced by AAV-EGFP-siCst1 do not show significant difference in the reaction to the 
NMDA induced excitotoxicity compared with the neurons transduced by 
AAV-EGFP-siNonsense control vector.  
 
Preliminary data show that there is no significant difference in the reaction to the 
excitotoxic insult between calsyntenin-1 knockdown neurons and Nonsense control 
neurons (p = 0.09, > 0.05).  
 
The data obtained from calsyntenin-1 knockdown experiments are insufficient by far to 
conclude that calsyntenins do not play a role in excitotoxicity. Most probably the 
calsyntenins may exhibit functional compensation amongst each other. Further extensive 
studies will be done when triple knockdowns of all three calsyntenins are achieved in 
neuronal culture. 
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V. Conclusions and Outlook 
 
We successfully set up a DNA vector-based small interfering RNA system, which 
has been proven to achieve specific and long-lasting gene down-regulation in 
several cell lines and in primary neuronal cultures. 
 
An AAV vector delivery system was established providing efficient gene 
transduction into neurons in primary neuronal cultures to achieve specific gene 
knockdown or over-expression. 
 
Co-transfected and endogenous calsyntenin-1 expression has been significantly 
down-regulated in cell lines and in primary neuronal culture, allowing studies of 
loss-of-function of specific genes. 
 
Preliminary data have been collected from morphological and functional studies 
providing a basic characterization of calsyntenin-1. The calsyntenin-1 knockdown 
did not show a notable influence on dendrite formation when evaluated by 
analyzing primary dendritic number. No impact of calsyntenin-1 on excitotoxic 
stress was detected in a NMDA-induced excitotoxic neuronal death model. 
 
The data obtained from these calsyntenin-1 knockdown experiments are 
insufficient to conclude that calsyntenins do not play a role in excitotoxicity. The 
calsyntenin members share highly conserved structures, suggesting potential 
functional compensation amongst each other. Extensive studies will be done when 
triple knockdown of all three calsyntenins is achieved by a vector containing siRNA 
cassettes against calsyntenin-1,2 and 3. 
 
Further morphological investigation such as the measurement of total dendritic 
length, secondary dendrite branching, and synaptic density will be conducted to 
give a more comprehensive understanding of the role which calsyntenins play in 
neuronal cell development. 
 
Calsyntenin suppression and over-expression in vitro and in vivo will be realized in 
the future with the rAAV vehicle. Reversible focal cerebral ischemia induced by 
temporary middle cerebral artery occlusion may serve as a useful model to answer 
the question whether the calsyntenins modulate excitotoxic neuronal cell death in 
vivo. 
 
The application of our vector-based siRNA system can be extended to study any 
other genes of interest by achieving loss-of-function. The system could be further 
modified to attain higher efficiency by replacing the loop sequence derived from 
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natural miRNA to improve export from the nucleus to the cytoplasm. Moreover, 
inducible elements could be introduced into the vector to achieve conditional 
knockdown of the target gene, which would help in avoiding the lethal effect 
associated with the deletion of certain genes. 
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SIDE PROJECT: Danio rerio Calsyntenin-1 
(By the helpf of Dr. Melody (Ying-yu) Huang from Prof.Dr. Stephan Neuhauss group) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Zebra fish calsyntenin-1 has been identified and reported to NCBI database (clone number: 
BC052116). The expression profile has been investigated with in situ hybridization (Figure 1). To 
look into the detailed expression pattern of calsyntenin-1 in zebra fish visual system, an in situ 
probe was designed according to the published cDNA sequence. Using cDNA obtained from brain 
tissue of zebra fish larvae, the PCR was perfermed for probe vector cloning. Instead of expected 
660bp fragment, a 2089bp one was obtained (Figure 2). The fragment was cloned into vector for 
sequencing. The sequence was searched in NCBI database. It was discovered that the sequence 
belongs to an unidentified cDNA clone (BC127396), which represent a splicing variant of reported 
zebra fish calsyntenin-1. But whether the splicing variation is tissue specific or developmental 
stages specific is not clear. The studay of zebra fish calsynentnin-1 may help to understand its’ 
highly conserved homologous in mammals. 
Figure 1: General expression profile of calsyntenin-1 in telencephalon, diencephalon, midbrain, hindbrain, 
spinal cord, cranial ganglia, pharyngeal pouches, lateral line and nose. 
Prim15 to Prim 25 stage (Thisse et al., 2004)
BC052116 
Fish Calsyntenin-1 
Whole body, adult 
Probe: 660bp 
954bp 
BC127396 
Unknown cDNA 
Olfactory epithelium, ? 
PCR product: 2089bp 
cDNA: brain tissue, larvae 
2864bp 
Figure 2: Identification of the splicing variant of zebra fish calsyntenin-1 in zebra fish larvae 
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